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Biofilms are microorganisms that inhabit inside a matrix made mainly of exopolysaccharides that 
are secreted from the micriobual consortia. Silver and copper ions efficacies have been proven in 
vitro, but, Huang, et al., (2008) confirmed the problem of biofilms altering the effects of these 
chemicals on the bacteria. The microbial killing effects of copper are in consequence of oxidation 
of the sulfhydryl groups of enzymes within the bacterial cell. The oxidation of these enzymes 
inhibits the enzymes activity halting the respiratory function of the cell, thus killing the bacterial 
cell (Pyle, et al., 1992). Silver nanoparticles increase the permeability of the cell membrane 
leading to cell leakage. The infiltration of silver ions in the mitochondria of the cell disrupts the 
ATP production by affecting the respiratory function enzymes resulting in the deformation of the 
chain that forms ATP. In a preceding study, biofilm bacterium were exposed to silver nanoparticles 
for various periods in 1mg and 2mg (per 25ml) concentrations. The results displayed a natural log 
delay with the required bacterial count being obtained at day 7. The research herein, was aimed 
at investigating the reduction of the effective time, the synergetic effects of copper nanoparticles 
and the application of nanoparticles in flow conditions. Concentrations of 10mg, 20mg and 50mg 
(per 25ml) of silver and copper nanoparticles were utilized in beaker and channel flow 
experimental setup varying the exposure time. A combination of copper and silver nanoparticles 
with concentrations 5mg ,10mg and 50mg were also tested in similar conditions to investigate the 
synergetic effects of the two heavy metals. In this experiment the silver nitrate and copper nitrate 
were reduced by citric acid and sodium hydroxide was used as the analytical agent. Given the 
results obtained, it is seen that the chemical application with flow aids the reduction of bacteria 
and the optimum concentration is between 10mg and 20mg (per 25ml) and it can be concluded 
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1. Introduction  
Biofilms are created by biofouling, which is the attaching of bacteria, fungi, viruses and other 
microorganisms to the inside surfaces of pipelines in distribution networks. Biofilm growth in 
distribution network pipelines lowers the quality of water supplied to the consumer, both health 
wise and aesthetically. Waterborne disease outbreaks have and will continue to occur due to the 
lowering of the water quality. This becomes a major problem if the biofilms are not cleaned out 
effectively. 
Surface roughness is increased over time due to the bacteria accumulation, thus changing the 
properties the pipeline was designed for. This change in roughness might cause change in the 
flow patterns and alter the energy requirements needed for pumping. This change in flow can 
cause cavitation that accelerates the deterioration of the pipes. 
In addition, these biofilms harbour harmful pathogens (bacteria, viruses, fungi, algae) and other 
micro-hazards. An ideal growing environment for bacteria is created by the biofilms outer mucus 
like layer provides protection for these, protection against certain disinfectants and the mechanical 
action of the water flow through the pipes. This results in delivered drinking water that has both 
odour, an unpleasant colour. Waterborne diseases such as typhoid, cholera and meningitis are 
caused by some of these bacteria such as Escherichia coli, Klesiella pneumoniae found in 
biofilms. 
Access to microbiologically safe drinking water is a basic need, however, biofilm removal methods 
that are available to control biofilm in drinking water distribution systems are either time 
consuming, expensive to carry out or may lead to human health risks if not properly executed. 
The presence of residual disinfectants such as iodine or chlorine, from the purification plant in the 
water is not enough to eradicate nor mitigate this issue. There are many ways that have been 
employed to try to clean out pipes all of which can be grouped into four categories. One of which 
is to do it mechanically. Mechanically cleaning entails manually scrubbing the pipes.  This type of 
method, however, can be labour intensive, time consuming, can be expensive and has a long 
down time on supply. The other of these methods makes use of biological agents which is 
achieved by introducing biological substances into the pipe network that will destroy or eat away 
the biofilm, this however is dangerous as some of these biological substances may be unsafe for 
human consumption and will be hard to completely flush out. Another way to remove biofilms is 
by altering the environment inside the pipes of the system by controlling the conditions such as 
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PH, temperature, hydrodynamics status and residual chemical composition. If the right 
environment is kept this will dramatically slow down biofilm growth. Problem is it is costly and hard 
to maintain such conditions in the pipe systems. The last of the four cleaning methods is to employ 
chemicals. This needs adequate cleansing before returning to the consumer depending on which 
chemicals have been made use of. The chemicals employed might also adversely react with the 
pipe material, giving rise to a new problem.  
Silver and copper ions efficacies on bacterial eradication have been proven in vitro, but Huang, 
et al., (2008) indicated the problem of biofilms altering the effects of these chemicals on the 
bacteria and suggests further study in this area. Silver nanoparticles display a wide range of 
biocidal activity to many microorganisms like, Fungai, algae, bacteria and viruses (Marambio-
Jones & Hoek, 2010). It is because of these properties of silver nanoparticles that its application 
to eradicate biofilms in water supply pipelines is being investigated. 
 
1.2 Research Scope 
If a solution can be found that is easy to implement, efficient and cost effective, this could help 
improve one of the most basic human right, the availability of safe drinking water and address the 
effects the biofilms have on the pipelines. Biofilms present a wide range of water quality and 
operational problems. Biofilms can be responsible for loss of distribution system disinfectant 
residuals, increased bacterial levels, reduction of dissolved oxygen, taste and odour changes, red 
or black water problems due to iron or sulphate-reducing bacteria, microbial-influenced corrosion, 
hydraulic roughness, and reduced materials life (Characklis and Marshal, 1990). Water quality 
issues can have drastic effects on consumer health. Legionarries disease is a kind of pneumonia 
illness that can be caused by the bacterium (Legionella pneumophila) found in water supply, even 
hot water reticulation systems (LIN, et al., 1996). Pseudomonas aeruginosa, Stenotrophomonas 
maltophilla and Acinetobacter baumannii are pathogens found in water systems and cause 
infections (Huang, et al., 2008). These bacteria are gram negative and found in chlorinated water 
systems. These pathogens have been linked to some lung infections and urinary tract infections. 
1.2.1 Research scope and question 
The general scope overview of this research can be summarised by the points below; 




− Concentration of nanoparticles to achieve acceptable levels of bacterial count within 
24hours or less. 
− Compare the results given by a beaker setup and a channel flow setup experiment.  
The general objective of this research is solely to investigate if the treatment using metal 
nanoparticles, namely silver and copper is effective enough to warrant further research to take it 
into industry. The above-mentioned research boundaries are due to the limitations listed below 
(1.2.2 Limitations) 
1.2.2 Limitations  
The limitations met by the experimental setup are listed below have suggested solutions 
suggested/given in Chapter 5 for future scope. 
− The biofilm growth time  
The pipelines that have either have operational or water quality issues due to biofilms 
have mature/thicker biofilms that have been grown over extended periods of time. The 
experiment presented herein is limited due to the level of maturity of the biofilms that are 
experimented on. This poses inaccuracies in the concentrations and time it might then 
take in an actual pipeline. 
− Growth and treatment environmental conditions 
In the experiments herein the biofilms are grown in a growth tank in lab conditions. This is 
a different environment as compare to the underground, high-pressured, high flow 
conditions that would be found in an actual pipeline. This difference can have different 
type/composition of biofilm present in the pipeline as compared to the coupons employed 
herein. 
− Bacterial count area percentage 
The percentage area of the coupons imaged is less than 25%. Although image location 
randomisation and a minimum of 10 images per coupon are used to attempt to get the 
best bacterial representation of the coupon surface area, the chances are high that 
clusters of bacteria are missed. 
− Chemical adhesion to apparatus surfaces  
The nanoparticles used have been observed to adhere to the surfaces of small diameter 
pipes. This will affect the concentration of nanoparticles that interact with the coupons. 




1.2.3 Methodology outline  
Below is a brief summary of the methodology of the entire research. The experimental accept of 
the study will be explained in depth in Chapter 3.  
 
Literature review  -    Determine the chemical components and synthesis. 
- Investigate antibacterial effects and health implications of the chosen 
chemicals. 
Experimental phase  -     Biofilm growth 
-     Channel and beaker treatment 
-     Imagery and count 
Results   -     Data generation 
- Data analysis 
 
 
1.3 Anticipated Results  
 
Anticipated results of the experiment: 
− Reduction in bacteria count on all samples (except the controls). 
− Treatment period to achieve acceptable bacterial count below 36hours. 
− Flow conditions to improve treatment time. 








1.4 Thesis Layout 
 
The research herein is presented as follows; 
Chapter 1:  Introduction - outlining the problem and giving the scope and or limitations of the 
research. 
Chapter 2: Literature review – exploration of relevant studies and experiments pertaining the 
research  
Chapter 3:  Methodology – an outline of the experimental and data analysis methodology 
Chapter 4: Results and Discussion – the display and explanation of the experimental results.  
Chapter 5: Concluding remarks – recommendation stemming from results and future scope 
suggestion  
Appendix A:   Tables, equations and figures pertaining to the methodology aspect of the research 














2. Literature Review 
Herein a review of past works and literatures pertaining to the chosen chemicals are reviewed, in 
addition to brief insights to their health impacts.  
2.1 Biofilm Background  
 
Chlorination has been the most widely used method of water purification since its antibacterial 
properties were discovered. Martinez-Gutierrez, et al., (2013) defines biofilms as microorganisms 
that inhabit inside a matrix made mainly of exopolysaccharides that are secreted from the 
microbial consortia. The biofilm shielded bacteria are resistant to antibiotics biocides and 
disinfectants when compared to free roaming cells. Its due to this reason that normal methods of 
disinfectants are not effective to biofilm (Pitts, et al., 2003). The microorganisms in the biofilm 
benefit from the exopolymer, or otherwise known as the slime layer. This layer offers protection 
from the external environment Biofilms greatly increase the antibiotic resistance of microbial 
organisms making it substantially more difficult to control colonization (Martinez-Gutierrez, et al., 
2013). Biofilms in addition protect pathogenic organisms from adverse environmental conditions. 
These become reservoirs for bacteria causing disease outbreaks (Martinez-Gutierrez, et al., 
2013).  The shear from the fluid flowing and the antibacterial agents are some of the factors that 
could kill, or slow down the growth of the biofilms (Martinez-Gutierrez, et al., 2013).  
 
2.1.1 Biofilm growth conditions 
 
Reducing the rate of biofilm removal by limiting its formation and slowing down the regrowth, 
makes more cost-effective sense to pipeline maintenance. Creating an environment within the 
pipeline that is not conducive for the biofilms limits biofilm growth. This can be achieved by altering 
some factors within the pipeline, such as:  
2.1.1.1 Environmental Factors 
Temperature within the pipeline is a major factor that is directly linked to the microbial growth rate. 
All the factors are affected by the temperature of the pipeline water indirectly or directly. 
Temperature of the water is difficult to control, and most water treatment plants do not have 
access to the equipment that is required to achieve this. Temperature can therefore be indirectly 
controlled by changing the levels of the other factors such as, the residual concentration of 
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disinfectant materials. Studies show that most microbial growth and activity happens at a certain 
optimum temperature higher than fifteen degrees Celsius. (Anon., 1992). Lag time between entry 
and multiplication is also greatly affected by the temperature of the water supply network, as is 
the growth rate. (Anon., 1992) 
Rainfall is an environmental factor that increases runoff and the microbial concentration in the 
untreated water. Runoff increases the amount of sedimentation in water treatment plant 
increasing the chances of breakthrough  
2.1.1.2 Sediment Accumulation  
The soil fines and particles that pass through the treatment phase increase the microbial growth 
rate by providing high amounts of carbon which is an essential part needed for growth. The 
sedimentation is not detected when breakthrough occurs because of a number of factors such 
as, their colour. These fines may carry with them bacteria. The low flow areas and depends of the 
water supply network accumulate a lot of the sedimentation. These areas become high bacterial 
zones. 
2.1.1.3 Corrosion  
Corrosion influences the rate of biofilm growth in a number of different ways, such as, reducing 
the water flow rate close to surface. This reduction in flow sequentially reduces shearing forces, 
therefore diminishing the shearing force that disturbs biofilm growth. Corrosion increases the 
surface roughness providing pits for bacteria to hide in. Corrosion can come about by, physical, 
chemical or biological action.  
2.1.1.4 Disinfection Residual Concentrations 
Although the presence of chlorine in the pipeline as residual disinfect minimal no effect on 
bacterial growth, some residual disinfectant in water supplies is needed. The absence of which 
results in the rapid undisturbed growth of biofilms within the pipeline.  
2.1.1.5 Nutrient Availability  
Certain substances are required to be the source of nutrients needed for microbial energy 
generation and cell multiplication the main nutrients needed for growth are phosphorous, nitrogen 
and carbon. Carbon is both, used for cell generation and an energy source to certain 
microorganisms. Bacteria (heterotrophic) need these three nutrients in a ratio of; carbon 100: 
nitrogen 10: phosphorus 1, carbon is usually the limiting one. carbon dioxide alone can be a 
source of carbon for the Bacteria. Nitrogen is used by microbial organisms to create amino acids 
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and genetic from. Nitrogen is released when vegetation decays, the nitrogen is dissolved and 
carried into raw water networks. Ammonia is the main source for nitrogen that is found naturally. 
Phosphate are sometimes introduced into network systems to control corrosion.  
2.1.1.6 Hydraulic Effects  
Increasing the flow will increase shearing, transport larger amount of disinfectant and cause 
greater flux of nutrients to the pipe surface this is a few examples of how altering the flow of the 
pipe network can affect the biofilm growth conditions (Anon., 1992). Water flow can be changed 
by fire hydrants, water main breaks, flushing and other factors due to the type and the design of 
water supply network and pipe size. Water hammer due to sudden closing of pipeline system also 
affects biofilm accumulation mainly by affecting sedimentation and corrosion. Water hammer 
could also result in pipe breakages leading to an influx of contaminates. 
 
2.1.2 Health implications of biofilm bacteria  
 
The bacteria and other microorganisms that inhabit the biofilm can be harmful to humans if 
ingested. Legionaries disease is a kind of illness that can be caused by the bacterium found in 
water supply, even hot water reticulation, systems (LIN, et al., 1996). These bacteria are known 
as Legionella pneumophila. Hospitals have tried to eradicate these bacteria a number of ways, 
for example, heat flushing, ozone UV light exposure, and hyperchlorination. These anti-bacterial 
methods have adverse disadvantages like, heat flushing will have bacteria grow back in short 
period of time and hyperchlorination will increase in corrosion of the pipe material (LIN, et al., 
1996). Pseudomonas aeruginosa, Stenotrophomonas maltophilla and Acinetobacter baumannii 
are pathogens found in water systems and cause infections (Huang, et al., 2008). These bacteria 
are gram negative and found in chlorinated water systems. These pathogens have been linked to 
some lung infections and urinary tract infections in hospitals. 
2.1.3 Biofilm control methods 
There are many ways that have been employed to try to clean out pipes all of which can be 
grouped into four categories. One of which is to do it mechanically. Mechanically cleaning entails 
manually scrubbing the pipes.  This type of method, however can be labour intensive, time 
consuming, can be expensive and has a long down time on supply. The other of these methods 
is biological cleaning. Biological cleaning is achieved by introducing biological substances into 
the pipe network that will destroy or eat away the biofilm, this however is dangerous as some of 
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these biological substances may be unsafe for human consumption and will be hard to completely 
flush out. Another way to remove biofilms is by altering the environment inside the pipes of the 
system by controlling the conditions such as pH, temperature, hydrodynamics status and residual 
chemical composition. If the right environment is kept this will dramatically slow down biofilm 
growth. Problem is it is costly and hard to maintain such conditions in the pipe systems. The last 
of the four cleaning methods is to employ chemicals. This needs adequate cleansing before 
returning to the consumer depending on which chemicals have been made use of. The chemicals 
employed might also adversely react with the pipe material, giving rise to a new problem.  
Silver nanoparticles display a wide range of biocidal activity to many microorganisms like, Fungai, 
algae, bacteria and viruses (Marambio-Jones & Hoek, 2010). It is because of these properties of 
silver nanoparticles that its application to eradicate biofilms in water supply pipelines is being 
investigated. Table 2.1 below gives a brief summary in some of the other available options of 
biofilm control. 
Table 2.1 Biofilm Control Methods 
 
Control Method Description / Notes 
Chemical  
E.g. Silver 
silver nanoparticles may destroy cell membranes because of the negative charge the 
membrane possesses. (Elechiguerra JL, 2005) This negative charge is called a free radical, 
an unpaired valence electron. Their extremely reactive free radical takes any chance it gets 
to bind, ripping apart anything it needs to, including the bacterial membranes. (Kannan N, 
2011)  
Physical   
i) Mechanically scrubbing the piplines 
 
ii) Control of environmental growth conditions: 
To reduce the frequency of biofilm removal by limiting its formation and regrowth, after 
removal is one way to make the maintenance issue as a whole more cost effective. 
Limiting biofilm growth is basically making an environment that is not conducive for the 
biofilms.  
A) Environmental Factors 
Temperature of water affects the microbial growth rate most. It has been observed that 
most microbial growth and activity happens at temperatures higher than fifteen degrees 
Celsius. (Anon., 1992).  
B)  Sediment Accumulation  
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The fines are not detected when breakthrough occurs because of their colour and may 
carry with them bacteria. The particles accumulate at dead ends and low flow areas of the 
water distribution network. 
C) Corrosion  
Corrosion influences biofilm growth in numerous ways such as, slowing down the water 
close to surface reducing shearing forces, sheltering biofilms from disinfectant and 
providing habitats. 
D) Disinfection Residual Concentrations 
Low levels of residual disinfectant in water supplies results in the undisturbed growth of 
biofilms.  
E)  Nutrient Availability  
Carbon is used for cell generation and can be an energy source. Bacteria (heterotrophic) 
need these three nutrients in a ratio of; carbon 100: nitrogen 10: phosphorus 1, carbon is 
usually the limiting one. Carbon sources from natural sources and could enter the system 
through pipe breaks.  
F)  Hydraulic Effects  
An increase in flow will increase shearing, and disturb biofilm gowwth. Water flow is 
altered by fire hydrants, water main breaks, flushing and other factors due to the design 
of network and pipe size. 
 
Ultrasound  
It is well established that ultrasonic cleaning baths, such as the Camlab device operating 
at 33 kHz, generate sufficient cavitation bubble activity to clean contaminating coatings, 
deposits and biofilms from metallic, glass, ceramic and plastic surface 
It has long been established that ultrasound provides an effective means of cleaning 
surfaces. The use of wide transducers with low surface energies in conventional 
ultrasonic cleaning baths allows the induction of cavitational bubble activity throughout 
the tank. It has also been established that extensive bacterial biofilm (10^cfu cm²) can be 
cleared from surface in this way. 
Shock waves 
There has been research on the feasibility of shockwaves as a method of removing 
biofilms. Results showing that shock waves have the ability to reduce the number of 
bacteria on a surface have been found (Philip Muller, 2011). Shock waves are able to 
greatly decrease adherent bacteria to an extent comparable to the control 
Biological 
Johansen et al. (1997) experimented on steel and polypropylene substrates which 
consisted of a model a biofilm which has four bacteria family groups: Staphylococcus 
aureus, Staphylococcus epidermidis, Pseudomonas fluorescens and Pseudomonas 
aeruginosa. Their experimental results concluded that a mixture of polysaccharide-
hydrolysing enzymes combined with oxidoreductases was able to remove biofilm from the 
substrate and stop bactericidal activity.  
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The usage of enzymes to remove biofilm is still restricted, due to the very high prices of 
the chemicals being used and the lack of techniques for quantitative evaluation of the 
effect of enzymes, as well as the lack of commercial availability of the different enzyme 
activities, limits their usage (Johansen et al., 1997). 
 
 
2.2 Silver Nanoparticles (Ag+) 
 
2.2.1 The antimicrobial effects of Silver (Ag) ion. 
Silver nanoparticles have displayed strong antibacterial properties and its applications can be but 
not limited to water and air purification, medical appliances cleansing, food production, clothing 
and cosmetics (Chen & Stewart, 2000) . Silver nanoparticle applications have been explored in 
various fields such as pharmaceutical engineering and medicine and has expanded considerably 
(Martinez-Gutierrez, et al., 2013). In medicine for example silver nanoparticles have been seen 
to reduce the microbial infections on wounds , in skin and also prevent bacterial colonization of 
medical instruments (Martinez-Gutierrez, et al., 2013). Silver has also been explored as an 
antibacterial agent in its many different forms such as stabilized silver salts, silver impregnated 
zeolite, silver-titanium dioxide composite Nano powders, silver chloride particles, polymer-silver 
nanoparticle composites, activated carbon materials, silver-coated polyurethane and silver-
dendrimer complexes and composites.  
Martinez-Gutierrez, et al., (2013) attributes the silver nanoparticle antibacterial effects to their 
unique physio-chemical abilities such as, high reactivity and high surface area to volume ratio. 
These characteristics result in silver nanoparticles being used in microorganism resistant drugs 
and other alternate products. Marambio-Jones & Hoek ,2010, confirms this and further describes 
the factors affecting the level of toxicity to bacteria of silver nanoparticles to be, shape and size, 
environmental factors such as pH and ionic strength, surface chemistry, crystallinity and capping 
agents. Particles with shapes that contain more facets like triangular particles tend to have the 
most antibacterial properties due to their stability. The stability of the silver nanoparticles has an 
effect on its effectiveness as antibacterial agent because the formation of aggregates causes a 
reduction in biocidal activity (Marambio-Jones & Hoek, 2010), as well as the readiness to release 
silver ions, that are stated by Lok et al., 2008, to be the cause of the antibacterial characteristics 
of silver nanoparticles. The more stable the chemical is the higher its antibacterial properties. 
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Silver nanoparticles properties such as shape, ionic strength and particle size lend to its stability 
and effectiveness (Marambio-Jones & Hoek, 2010).   
Silver has antibacterial properties in many different forms apart from metallic silver nanoparticles 
such as stabilized silver salts, silver impregnated zeolite, silver chloride particles, activated carbon 
materials, to name a few. These forms of silver are already being utilized in various products 
(Martinez-Gutierrez, et al., 2013). The release of the silver ion is thought to be the primary reason 
for these antibacterial characteristics that silver has (Marambio-Jones & Hoek, 2010). Silver 
antimicrobial characteristics are achieved by three main ways when the silver ion interacts with 
the cell The release of these ions is then followed by the damaged cell wall structure increasing 
the cell permeability, cell leakage, loss of the proton motive force and damage to the RNA and 
DNA (Marambio-Jones & Hoek, 2010). All these following consequences of the ions interacting 
with the microbial cell then results in the eradication of the bacteria. Details of these three ways 
are given below. 
2.2.1.1 Cell entry 
When silver is reduced to the nanoscale it gains charge, this is an important part of the destruction 
of the bacterial cell membrane. The positively charged silver ions get attached to the cell walls 
and vacuoles of bacteria, this damages cell envelope and cell wall structure, cytoplasmic 
membrane, and its contents. Silver nanoparticle ions damage and increase the permeability of 
the cell membrane. The interaction of the silver nanoparticle with the bacterial cell membrane 
leaves pits in the membrane when the silver ion enters the cell (Marambio-Jones & Hoek, 2010). 
This leads to cell leakage and the uptake of external hazards into the cell.  
The microbial cell membrane possesses negative charge which is called a free radical. This 
unpaired valence electron is and will bind with anything it can rapturing anything it needs to reach 
equilibrium. The silver ions are positively charged and bind with the cell membrane damaging it. 
(Kannan N, 2011) . silver ions have a high affiliation to phosphorous and sulphur within the cell 
membrane. This allows the silver nanoparticles to attach to the cell wall and penetrate it leaving 
pits and pores on the damaged surface (Alexa M. Königs, 2015). The bacteria are now susceptible 
to cellular leakage, where the cytoplasm pours out into the extracellular fluid carrying with it key 
intracellular components of the cell  (Gurunathan, et al., 2014). 
2.2.1.2 Protein inactivation and DNA interruption  
The infiltration of silver leads to the positively charged ions disrupting the ATP production and 
DNA replication (Marambio-Jones & Hoek, 2010). The silver ions are released from the silver 
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nanoparticles. This occurs in the mitochondria of the cell (Marambio-Jones & Hoek, 2010). The 
free silver ions interact with the respiratory function enzymes resulting in the deformation of the 
chain that forms ATP (Marambio-Jones & Hoek, 2010).  Silver also the joins to the proteins 
causing proton leakage. Silver inhibits the uptake of phosphate; this inhibits the DNA from 
functioning and replicating. The extensive production of reactive oxygen species, which is a by-
product of the cellular respiratory mechanism, creates free radicals which attack membrane lipids 
causing the breakdown of the cell membrane (Marambio-Jones & Hoek, 2010). These high levels 
also interfere with mitochondria function and DNA damage (Marambio-Jones & Hoek, 2010). 
Silver acts as a catalyst in the generation of these reactive oxygen species. Silver nanoparticles 
are also responsible of reducing the levels of glutathione disulphide which an antioxidant which 
control the levels of reactive oxygen species (Marambio-Jones & Hoek, 2010). 
Silver nanoparticles have proved in vitro to be effective in killing the bacteria such as, Klebsiella 
pneumonia staphylococcus epidermis, Leuconostoc mesenteroides, Escherichia coli, Klebsiella 
mobilis and. staphylococcus aureus, which are the main bacteria found within biofilms found in 
water pipes (Marambio-Jones & Hoek, 2010). In addition to these bacteria silver nanoparticles 
have proven to have adverse effects on some Fungai that have been in biofilms such as 
Saccharomyces cervisia, Aspergillus, Penicillium citrinum and Candida albicans. Silver also kills 
a few viruses such as hepatitis B and syncytial virus (Marambio-Jones & Hoek, 2010) 
Martinez-Gutierrez, et al., (2013) tested the antibacterial effects of silver in its nanoparticle form. 
The biofilms treated were formed in both static and fluid flow conditions. A reduction in bacterial 
clusters of Pseudomonas aeruginosa was obtained. Martinez-Gutierrez, et al., (2013) concluded 
that silver nanoparticles both prevent the growth of bacteria and remove the biofilms that have 
already been formed. This makes silver nanoparticles a viable option in the control of biofilm 
bacteria control.  
In the experiment carried out by Huang, et al., (2008),  the treatment of microorganisms with silver 
nanoparticles resulted in the inhibition of the biofilm formation. Huang, et al., (2008) also recorded 
that p. aeruginosa was the most affected bacteria to the silver nanoparticle treatment and resulted 
in a log 2 reduction. The anti-bacterial effects of silver nanoparticles against Staphylococcus 
epidermidis and E. coli was also investigated. These above-mentioned bacteria are the most 
common in aquatic formed biofilms.  The overall results of the study carried out by Huang, et al., 
(2008) show that silver nanoparticles are toxic to bacteria that are mainly found in biofilms. From 
these results it is noted that higher concentrations of silver nanoparticles are needed to completely 
kill microbes that are inside biofilms. Stenotrophomonas maltophilla, Acinetobacter baumannii 
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and Pseudomonas aeruginosa are all susceptible to silver ions and will be completely eradicated 
within 3 day (Huang, et al., 2008) s. 
In the research by Sheng, et al., (2015) silver nanoparticles were observed inside the biofilm after 
only forty-five minutes of exposure. Within 24h the silver nanoparticles had infiltrated the microbial 
cells and started killing them off. Sheng, et al., (2015) tested the power of silver nanoparticles on 
waste water formed bacteria. Silver nanoparticle have harmful effects even on the wastewater 
biofilm bacteria (Sheng, et al., 2015). Apart from the direct killing of the microbial cells by the silver 
nanoparticles they also inhibit nitrification even at low concentrations of about 1mg Ag/L (Sheng, 
et al., 2015). 
Bouryabaf, et al., (2017) researched the efficacy of agar hydrogel with silver nanoparticles to 
remove biofilms and kill bactreia, mainly Staphylococcus aureus. From the reuslts it can be 
concluded that, silver nanoparticles were essentail in the killing the bactria and can be used as 
an effective antibacterial agent. Silver nanoparticves attack the bacterial cell mebrane, interact 
with theprotiens containing sulfur, and cause disruption and alter phophorous containing 
compounds like the celluar DNA (Bouryabaf, et al., 2017). Silver nanoparticles have been seen 
to have adverse effects on , Escherichia coli, Listeria monocytogenes, pseudomanas aeruginosa, 
klebsiella pneumoniae and proteus mirabilis (Bouryabaf, et al., 2017). 
Thurman, et al., (1989) reported that it’s the concertration of silver oions that is respoincble for its 
antibacterial properties and not its physical nature. Silver ions are known to be toxic to E coli , 
Bacillius typosus, Staphylococcus Pseudomonas , Streptococcus and Salmonella (Thurman, et 
al., 1989). This list contains bacteria that are resistant to antibiotics and some viruses are also 
subject to it effect.  
 
2.2.2 The disadvantages of using Silver (Ag) as an antibacterial agent. 
Marambio-Jones & Hoek (2010) reviewed that the use of silver nanoparticles has no documented 
immediate impacts to human health or the environment, although more research is needed before 
implementation of any silver nanoparticle product. Bacteria can develop resistance or become 
less sensitive to toxicants by natural selection in environments where these antimicrobials are 
present. The wide use of silver in many forms may have cultivated some silver resistant bacteria 
(Marambio-Jones & Hoek, 2010).The bacterial resistance to silver and other heavy metals is 
mainly encoded within the plasmid genes of the bacteria, but chromosomes could also encode 
silver resistant genes (C Baker, 2005). The increasing population of resistant bacteria makes 
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uncertain the efficacy of silver nanoparticles as an antimicrobial agent. The presences of halides 
such as chloride, bromide and iodide, can decrease the silver bioavailability and by so doing 
reduce the exposure of silver to bacteria (Chen & Stewart, 2000). Minimising the bacteria 
exposure to silver increases its effectiveness when its applied for antibacterial purposes. 
Allot of silver containing products are being developed. This however calls for more research into 
its effects and risks on humans and to the environment. Although silver has its advantages of 
being toxic to bacteria the assessment of its harmful potential to humans and the ecosystem 
associated with its utilization need to be investigated further Marambio-Jones & Hoek (2010) 
states. Prokaryotic and eukaryotic cells are different but understanding the ways in which silver 
kill bacterial cells, one can see the potential of silver nanoparticles to hurt even mammalian cells. 
Silver nanoparticles attack cell components such as the mitochondria which are present in both 
prokaryotic and eukaryotic cells. The fundamentals of mitochondrial function are the same in both 
bacterial cells and mammalian cells (Marambio-Jones & Hoek, 2010). Functions that are essential 
to the cell survival like, ATP synthesis, electron transport, respiration and proton motive force, are 
like prokaryotic and eukaryotic cells. In theory, it is thought that silver could affect the function on 
higher cellular organisms via the same ways it kills bacterial cells, if the silver can enter the cell 
(Marambio-Jones & Hoek, 2010). Human exposure to silver nanoparticles would be mainly 
through the respiratory system, digestive system and through the skin. In addition, other ways in 
which silver exposure can occur are by being exposed to wounds, through wound dressing and 
antibacterial products and the female genital tract, through hygienic, and contraceptive products. 
In addition to silver anti-bacterial effects Marambio-Jones & Hoek (2010) reviews that silver can 
also have negative effects in higher cell species like zebra, rodents and fish. In rodents silver 
damages the internal organs such as the lungs and liver, and silver also penetrates the blood 
brain barrier (Marambio-Jones & Hoek, 2010). One study in human cells showed that silver can 
be genotoxic (C Baker, 2005).  
 
2.2.3 Silver nanoparticle synthesis 
Kamali (2011) investigated the synthesis of silver nanoparticles using chemical reduction, using 
Silver nitrate, citric acid and sodium hydroxide. This investigation resulted in the formation of silver 
nanoparticles proving the efficacy of citric acid as a complexing agent. Kamali (2011) found that 
addition of ammonium hydroxide have effects on the particle size but the particle purity is 
increased when nitric acid is introduced. The purity, size and morphology of silver nanoparticles 
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strongly affect there chemical and physical properties and as such different approaches of 
synthesising them have been adopted. Namely, microwave irradiation, chemical deduction, green 
synthesis, gamma irradiation and thermal methods (Kamali, 2011).  
Huang, et al., (2008) sythesised silver ions using silver chloride dissolved in ionised water. The 
most common method of synthesising silver nanoparticles is a chemical reaction by which a 
dissolved silver salt is reduced by a compound such as citrate, ascorbate, glucose and hydrazine 
(Marambio-Jones & Hoek, 2010). Grouchko, et al., (2009) used silver anaoparticles that where 
sythesised by a chemical method reducing silver nitrate by trisoduim citrate. 
 
 
2.3 Copper Nanoparticles (Cu2+) 
 
2.3.1 The antibacterial effects of Copper. (I and II) 
Cooper ions have been used to eradicate bacteria in hospital water reticulation systems. Copper 
ions have been recorded to inactivate Legionella pneumophila under 3hours with concentrations 
of about 0.1mg/l (LIN, et al., 1996). Copper has also been employed as an algicide (Thurman, et 
al., 1989). It is one of the most effective in killing heterotrophic bacteria in water-based 
environments. Thurman, et al., (1989) discovered that copper at 0.2 mg/L inactivates the 
infectious virus, bronchitis in only two hours. It is also very toxic to E coli. Hassen, et al., (1998) 
tested the effects of copper on Pseudomonas aeruginosa and bacillus thuringinesis and noted 
that at 0.2mM inhibited bacterial growth. The intric properties of copper and effect on the bacteria 
cell wall were credited for the antibacrtail charateristics displayed by the copper. Bacillus 
thuringinesis however did not have as significant reduction when exposed to copper as compared 
to other heavy metals (Hassen, et al., 1998) Copper ion totally eradicates Pseudomonas 
aeruginosa when its treated with copper (Huang, et al., 2008). Pseudomonas aeruginosa is more 
susceptible to copper ion treatment compare to Stenotrophomonas maltophilla and Acinetobacter 
baumannii.  
The microbial killing effects of copper is closely in connection with oxidation of the sulfhydryl 
groups of enzymes with in the bacterial cell (Pyle, et al., 1992). The oxidation of these enzymes 
inhibits the enzymes activity (Pyle, et al., 1992). The enzymes inhibition affects the raspatory 




2.3.2 The disadvantages of using Copper (Cu) as an antibacterial agent.  
Humans are exposed to Copper in varies ways in day to day living, and the known effects of 
chronic excess copper exposure on health is insufficient (Araya, et al., 2005). Copper is one of 
the necessary micronutrients needed in many processes of life, but can be toxic and harmful to 
cell membranes, proteins and DNA if exposed to high amounts. High levels of copper have been 
seen to collate with Wilson’s disease (Araya, et al., 2005).   Test was carried out by Araya, et al., 
(2005) exposing various gender and age groups of people to a daily dose of 10mg Cu/day for 60 
days. Observed was enzymes in the liver increased greatly in all test samples but still below 
clinical liver dysfunction levels. 
In other studies, it was found that foetus development is affected negatively by the deficits of 
copper, and excessive exposure is also risky (Uriu-Adams & Carl, 2005). Liver disease and 
severe neurological defects are some of the additional results of chronic copper exposure (Uriu-
Adams & Carl, 2005). Tissue damage is also caused by oxidative stress by both copper deficiency 
and toxicity (Uriu-Adams & Carl, 2005). The oxidative stress caused by the high levels of copper 
is because of its redox reactivity. The copper could also attach to the free this of cysteines. This 
causes oxidation and crosslinks that impair protein activity (Uriu-Adams & Carl, 2005). Many 
cases recorded in literature report toxicity due to ingestion of liquids that have been contaminated 
with copper. Symptoms of chronic copper exposure include nausea, vomiting, abdominal pain, 
liver and kidney failure, headache, respiratory difficulties and gastrointestinal bleeding. Copper 
toxicity could occur through the skin and respiratory tract of a human (Uriu-Adams & Carl, 2005).  
Wilson’s disease is a genetic disorder disease caused by copper. It’s an autosomal recessive 
disease and has a heterozygous carrier rate of about 1:100, with an estimated prevalence of 1:30 
000 (Uriu-Adams & Carl, 2005). The overload of copper that happens within the body results with 
liver pathogenesis that is a consequence of Wilsomkin’s disease. Liver failure causes death. 
Alzheimer disease, Amyotrophic lateral sclerosis and Creutzfeldt-Jakob disease are connected 
to the high amounts of copper that accumulate in regions of the brain. 
 
2.3.3 Copper nanoparticle synthesis 
Chemical reduction method of synthesising copper nanoparticles is one of the most widely used 
do to its ability to vary the attributes. such as size purity morphology and stability, of the particles 
to the user’s needs (Grouchko, et al., 2009). Reducing agents used in chemical methods have to 
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be strong, for example, hydrazine, sodium borohydride (Grouchko, et al., 2009), hydrogen 
amongst many.  
 Grouchko, et al., (2009) achieved well dispersed copper nanoparticles by reducing copper nitrate 
solution using hydrazine monohydrates as a reducing agent. This was carried out in the presence 
of silver nanoparticles to catalyse the reaction. In this investigation it was found that the rate of 
formation of copper nanoparticles was significantly by the silver nanoparticles. In other studies 
Huang, et al., (2008) sythesised copper ions using copper choride dissolved in ionised water and 
Jadhav, et al., (2011) prepared copper oxide ananoparticles by electrochemical reduction. Tetra 
butyl ammonium bromide was used in this sythesis as a structure directing agent.  
 
2.4 Combined Effects of Silver and Copper 
 
2.4.1 Antibacterial effects of heavy metals 
Heavy metal group which contains copper and silver includes other transition series metals from 
the periodic table. Within the metallic element groups there are heavy metals such as zinc, 
mercury, bismuth, cadmium, chromium, copper and silver that show antibacterial characteristics 
(Top & Ulku, 2004). These heavy metals react with and impart their antibacterial properties onto 
zeolites. Heavy metals been recorded to be harmful to Pseudomonas aeruginosa and Escherichia 
coli (Top & Ulku, 2004). Zinc oxide nanoparticles PVC composite surfaces reduces 
Staphylococcus aureus biofilm formation. Silver and copper are both heavy metals. Heavy metals 
have antibacterial properties and are used as antibacterial agents (LIN, et al., 1996).  Hassen, et 
al., (1998) confirms that heavy metals are toxic to bacteria. Mercury and copper have been found 
to the elements that affect Pseudomonas aeruginosa and bacillus thuringinesis the most after 
testing the six most readily avalable metals, namely; copper, zinc, cadium,chromium, mercury 
and coblat.  
 
2.4.2 Synergistic antibacterial effects of Silver and Copper  
The antibacterial characteristics of silver and copper ions is heavily attributed to their positive 
ions. These ions are microbiocidal because of their charge they attached to the bacteria cell wall 
and increase the cell wall permeability (LIN, et al., 1996). This leads to cell leakage and 
interference with proteins inside the cell and results in cell death. There have been many 
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publications that document the use of Copper and silver ions in control of bacteria, viruses, algae 
and fungi in water (Pyle, et al., 1992). Both silver and copper ions interfere with the enzyme’s 
activities of the cell, inhibiting critical cellular function such as respiration. Although chlorine, which 
is the most common antibacterial agent used in purifying water , has quicker antibacterial action, 
there is an synergetic effect when its used in combination with silver and copper (Pyle, et al., 
1992). The combination or individual applications of silver and/or copper ions is being used in 
over 300 hospitals in the world to purify their portable water systems (Huang, et al., 2008). The 
efficacies of silver and copper ions to eradicate bacteria has been proven a number of times 
(Huang, et al., 2008). They have been effective in killing Legionella, Pseudomonas cepacia, 
Naegleria fowleri and Poliovirus.  Copper and silver ions have a synergetic effect when they are 
used to treat Pseudomonas aeruginosa and Acinetobacter baumannii.  
The combined effects of treating Legionella pneumophila, a bacteria found in water reticulation 
systems, with both copper and silver ions yielded more favourable results than using the two 
chemicals separately (LIN, et al., 1996). Lin, et al., (1996) observed that the concentrations of 
silver ions and copper ions needed to kill the bacteria individually were more than double 
compared to the concentration of the mixture of the two chemicals to achieve the same result. 
Lin, et al., (1996) also showed that synergy between silver and copper ions exists. 
The combination of silver and copper nanoparticles has been tested and resulted in the reduction 
of bacterial cells (Pyle, et al., 1992) far quicker than either of the two elements alone. Pyle, et al., 
(1992) also tested silver and copper antibacterial effects in combination with another halogen, 
iodine. Observed was that the presence of the metal enhanced the action of the halogen 
antibacterial effects (Pyle, et al., 1992), and as with chlorine the combination yielded much better 
results than the individual treatments . The combination of copper and silver with a halogen would 
be best suited in area where a high count of coliform bacteria  have been located in water 
distribution networks (Pyle, et al., 1992). The one down fall of using these metals is that they tend 
to gravitate towards the surface leaving small amounts of metal ions in the liquid form (Pyle, et 
al., 1992). However, they reduce and inhibit the formation of biofilms in pipelines. They also make 
halogen disinfections more effective in places where biofilms have already taken root in systems 





3. Methodology  
In a preceding study, biofilm bacterium was exposed to silver nanoparticles for various periods in 
1mg and 2mg (per 25ml) concentrations. The results displayed a natural log delay with the 
required bacterial count being obtained at day 7. The research herein, was aimed at investigating 
the reduction of the effective time, the synergetic effects of copper nanoparticles and the 
application of nanoparticles in flow conditions. Concentrations of 10mg, 20mg and 50mg (per 
25ml) of silver and copper nanoparticles were utilized in beaker and channel flow experimental 
setup varying the exposure time. A combination of copper and silver nanoparticles with 
concentrations 5mg ,10mg and 50mg were also tested in similar conditions to investigate the 
synergetic effects of the two heavy metals. Grouchko, et al., (2009) used silver nanoparticles that 
where synthesised by a chemical method by reducing silver nitrate by trisoduim citrate. Grouchko, 
et al., (2009) achieved well dispersed copper nanoparticles by reducing copper nitrate solution 
using hydrazine monohydrates a reducing gent. This was carried out in the presence of silver 
nanoparticles to catalyse the reaction. In this experiment the silver nitrate and copper nitrate were 
reduced by citric acid. Mortar sample coupons were used because eThekwini uses steel pipes 
with mortar lining for clean water delivery. Below the description of each stage of the experiment 
is given.  
3.1 Biofilm Cultivation  
3.1.1 Mortar sample  
Cement mortar mix to fabricate the samples was made using these guidelines: 
• Ordinary Portland Cement (OPC) complying with requirements of SABS 471/SANS 50197-
1(new code) 
• Water used shall be free from injurious amounts of acids, alkalis or substances that may impair 
the strength or durability of the cement mortar lining 
• The aggregate shall be specially graded washed silica sand complying with the grading 
requirements of SABS 1090 table1 column3, and shall comply with SABS 1083/SANS 
1083(new code) in respect of organic impurities and dust content 
• Cement, aggregate and water can be mixed to an accuracy of 20% of the mass required. All 
mortar shall be mixed in suitable mortar mixers. No hand mixing to be permitted 
• The total content of cementitious materials shall not be less than 600kg/m^3 
• The total water content shall be the minimum required to produce a suitable consistency for 
application of the lining, but water: cement ratio shall not exceed 0.45:1 by mass 
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• The finished surface shall be free of excessive laitance, the maximum acceptable thickness 
being 10% of the total lining thickness or 1.25mm, whichever is the lesser 
The concrete mortar sample made is about 10mm by 5mm as seen in Figure 3.1 below. 
 
Figure 3.1: Concrete coupon samples 
3.1.2 Growth incubation  
The concrete samples were placed in a growth tank with flowing tap water and covered to block 
the sunlight. The tank was kept in a cool area so to mimic the underground pipe conditions as 
seen in Figure A.6 in appendix A  
Samples were left in the tank for over 150 days to allow adequate growth on the samples. 
 
3.2 Beaker Set-up  
Samples were exposed to the chemicals for different periods in stagnant solution in  beakers. 
Table 3.1 summaries this procedure. 3 sets of control samples were taken from the growth tank 
and preserved without treatment for each tested time period. Nine solutions of chemicals were 





Figure 3.2:Prepared nanoparticle chemicals 
 
Figure 3.3: Treated samples in beakers 
 
 
Table 3.1: Beaker set-up sample treatment summary 
 
(0L/s flow) 3HRS 12HRS 24HRS 
Silver  































































0mg 0mg 0mg 
(3 samples) (3 samples) (3 samples) 
 
 
3.3 Channel Set-up  
3.3.1 Design  
The channel apparatus was designed to test effects of the flow and the chemical concentration 




Figure 3.4: Channel set-up experiment 
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The supply and collection tanks have 3 sections as shown in figure 3.4. Each section is connected 
to 2 channels. Each channel has an adjustable tap to regulate the flow. Each channel has 3 slots 
to place samples. 
The channel experiment is open flow and has very little flow as compared to the high pressured 
pipelines used in distribution networks. Although these conditions may be different it is a good 
investigation to how the nanoparticles behave in moving water as supposed to the stationary 
conditons application of the beaker experiments.  
 
3.3.2 Procedure  
The samples were transferred from the growth tank into the channel slots for each of the 3 tests. 
The 3 tests were done with 3 different chemicals. Silver nanoparticles, Copper nanoparticles and 
a mixture of Silver and copper nanoparticles. Each test had 3 different nanoparticle 
concentrations. The samples were subjected to 2 different flows of the same concentration.  A 
control group was taken from the growth tank at the beginning of each test and preserved for 
processing. Samples were tested in triplicates. All tests were run for 12H. The Table 3.2 below 
illustrates the above procedure.  
Table 3.2: Channel set-up sample treatment summary 
 
(12hrs run time) FLOW 1 FLOW 2 CONTROL 
Silver  














































The average flows of each channel during each test are recorded below in Table 3.3. The 







Table 3.3: Flow rates during channel set-up experiment 
 
Ave Flows of Channel Exp. 
Silver 
Fast Flow Slow Flow 
0.0191 0.0068 
Copper 








3.4 Chemical Synthesis  
The ratio of Silver Nitrate and Copper Nitrate to Citric Acid to give the required nanoparticle 
concentrations are:  
Ratio of Silver (Ag)  : Citric      -  1: 2.47      
  (Cu)  : Citric  - 1: 2.47 
Kamali, (2011), had ratio of   1.7 : 4.2. The same procedure was taken but calculations were done 
from first princeples by making use of the formlua: 
 
   M  =      V  x      1/MMm  x           MMs  x Ratio 
(mass)   (volume) (molar mass metal)  (molar mass of salt) 
 
The masses need to be dissolved in distilled water to make the desired concentrations are noted 




3.4.1 Analytical Reagent Synthesis 
Sodium Hydroxide was used as the analytical reagent. 1 molar of this solution was added to the 
chemical mixtures as stipulated in the tables below. The 1 molar solutions were made as follows:  
      NaOH (mass)   Water (distilled) 
Sodium Hydroxide (1M)   20g    500ml 






3.4.2 Silver nanoparticle synthesis  
Table 3.4: Silver nanoparticle synthesis (250ml solution) 
 
Silver nanoparticle - 250 ml solution – Beaker setup 
NANOPARTICLE 
CONCENTRATION 
CHEMICAL MASS (mg) 
10mg/25ml 
Silver Nitrate AgNO3  157.50 
Citric Acid C6H8O7.H2O 389.03 
20mg/25ml 
Silver Nitrate AgNO3  314.98 
Citric Acid C6H8O7.H2O 778.00 
50mg/25ml 
Silver Nitrate AgNO3  787.50 
Citric Acid C6H8O7.H2O 1 945.10 
1M Sodium Hydroxide NaOH 
50ml added to all the 





Table 3.5: Silver nanoparticle synthesis (5000ml solution)  
 
Silver nanoparticle - 5000 ml solution – Channel setup 
NANOPARTICLE 
CONCENTRATION 
CHEMICAL MASS (mg) 
10mg/25ml 
Silver Nitrate AgNO3  3 149.80 
Citric Acid C6H8O7.H2O 7 780.00 
20mg/25ml 
Silver Nitrate AgNO3  6 299.60 
Citric Acid C6H8O7.H2O 15 560.00 
50mg/25ml 
Silver Nitrate AgNO3  15 749.10 
Citric Acid C6H8O7.H2O 38 900.00 
1M Sodium Hydroxide NaOH 
1000ml added to 
each solution and 
heated at 250 
3.4.3 Copper nanoparticle synthesis: 
Table 3.6: Copper nanoparticle synthesis (250ml solution) 
 
Copper nanoparticle - 250 ml solution – Beaker setup 
NANOPARTICLE 
CONCENTRATION 
CHEMICAL MASS (mg) 
10mg/25ml 
Copper Nitrate Cu (NO3)2  189.60 
Citric Acid C6H8O7.H2O 468.40 
20mg/25ml 
Copper Nitrate Cu (NO3)2  379.29 
Citric Acid C6H8O7.H2O 936.85 
50mg/25ml 
Copper Nitrate Cu (NO3)2  948.20 
Citric Acid C6H8O7.H2O 2 342.10 
1M Sodium Hydroxide NaOH 
50ml added to each 





Table 3.7: Copper nanoparticle synthesis (5000ml solution) 
 
Copper nanoparticle - 5000 ml solution – Channel setup 
NANOPARTICLE 
CONCENTRATION 
CHEMICAL MASS (mg) 
10mg/25ml 
Copper Nitrate Cu (NO3)2  3 792.90 
Citric Acid C6H8O7.H2O 9 368.40 
20mg/25ml 
Copper Nitrate Cu (NO3)2  7 585.80 
Citric Acid C6H8O7.H2O 18 736.90 
50mg/25ml 
Copper Nitrate Cu (NO3)2  18 964.40 
Citric Acid C6H8O7.H2O 46 842.10 
1M Sodium Hydroxide NaOH 
1000ml added to each 
solution and heated at 
250 
 
3.4.4 Silver + Copper nanoparticle synthesis 
Table 3.8: Silver and Copper nanoparticles mixture synthesis (250ml solution) 
 
Silver + Copper nanoparticle - 250 ml solution – Beaker setup 
NANOPARTICLE 
CONCENTRATION 
CHEMICAL MASS (mg) 
5mg/25ml 
Silver Nitrate AgNO3  78.75 
Copper Nitrate Cu (NO3)2  94.80 
Citric Acid C6H8O7.H2O 428.67 
10mg/25ml 
Silver Nitrate AgNO3  157.50 
Copper Nitrate Cu (NO3)2  189.60 
Citric Acid C6H8O7.H2O 857.30 
20mg/25ml 
Silver Nitrate AgNO3  314.98 
Copper Nitrate Cu (NO3)2  379.30 
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Citric Acid C6H8O7.H2O 1 714.90 
50mg/25ml 
Silver Nitrate AgNO3  787.50 
Copper Nitrate Cu (NO3)2  948.20 
Citric Acid C6H8O7.H2O 4 287.20 
1M  Sodium Hydroxide NaOH 
50ml added to each 









Table 3.9: Silver and Copper nanoparticles mixture synthesis (5000ml solution) 
 
Silver + Copper nanoparticle - 5000 ml solution – Channel setup 
NANOPARTICLE 
CONCENTRATION 
CHEMICAL MASS (mg) 
5mg/25ml 
Silver Nitrate AgNO3  1 574.90 
Copper Nitrate Cu (NO3)2  1 896.50 
Citric Acid C6H8O7.H2O 8 574.40 
10mg/25ml 
Silver Nitrate AgNO3  3 149.80 
Copper Nitrate Cu (NO3)2  3 792.0 
Citric Acid C6H8O7.H2O 17 148.50 
20mg/25ml 
Silver Nitrate AgNO3  6 299.60 
Copper Nitrate Cu (NO3)2  7 585.80 
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Citric Acid C6H8O7.H2O 34 296.90 
50mg/25ml 
Silver Nitrate AgNO3  15 749.10 
Copper Nitrate Cu (NO3)2  18 964.40 
Citric Acid C6H8O7.H2O 85 742.30 
1M  Sodium Hydroxide NaOH 
1000ml added to 
each solution and 







3.5 SEM Processing of Images  
The preparation procedure for testing & imaging samples has 3 processes after the sample has 
been extracted from the experiment. 
3.5.1 Preservation: 
Extracted samples are preserve in 2.5% Glutaraldehyde (can be refrigerated for a minimum of 2 
hours up to 2 weeks). The purpose of glutaraldehyde is to stabilize the sample and neutralise all 
metabolic activity of the biofilm on the sample. After a minimum of 2 hours, the sample can then 
be unrefrigerated and thereafter transited to the laboratory. It should be transferred to the lab fully 
submerged in the fixative solution.  
3.5.2 Dehydration: 
The dehydration procedure is as follows: 
1. Buffer wash using 2.5% Glutaraldehyde for 3 x 5 min 
2. Submerge in 30% Alcohol for 2 x 5 min 
3. Submerge in 50% Alcohol for 2 x 5 min 
4. Submerge in 75% Alcohol for 2 x 5 min 
5. Submerge in 100% Alcohol for 2 x 10 min 
After dehydration the samples need to be left overnight in a dark room to air dry. 
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The above process dehydrates the samples using various concentrations of alcohols to enable 
the samples to be used in the SEM. The dehydration process extracts all water from the sample, 
both surrounding the samples and in the pores of the material of the samples. It also eliminates 
any further biotic activity on the samples.  
Once the samples have been air dried, they are then be gold plated. The samples are gold plated 
using a plasma gold plating device. The samples are coated with 2 layers of gold particles to 
enable conduction of the electrons in the SEM and the sample. 
 
3.5.3 SEM Process: 
A scanning electron microscope (SEM) is a form of electron microscope that draws images of a 
sample by scanning it with a focused beam of electrons. The electrons interact with atoms in the 
sample, emitting various signals that contain information about the sample's surface topography 
and composition. 
Once the desired position is produced, an image is captured storing all the information in the data 
attached to the image. A minimum of 5 images need to be captured per sample to allow for an 
acceptable level of accuracy. A variety of positions on the sample need to be surveyed. 
 
 











4. Results and Discussion 
4.1 Overview 
From the 51 samples used, a total of 765 images were taken from the SEM and processed. Within 
those there were 6 control groups. From this large pool of data various comparisons can be drawn. 
The beaker setup primarily examines the different effectiveness of the different concentrations of 
each chemical used. It also gives data into the combined effect of the Silver and Copper 
nanoparticles. The channel setup gives the effects of flow on the treatment of the bacteria using 
these chemicals. The beaker experiment acts as the zero-flow condition for the channel setup. 
From the results of both setups, as seen in the summary in Figure 4.10, an effective time can be 
determined. 
4.2 Biofilm Growth  
The samples were left in the growth tank for approximately 153days before the first samples were 
taken out for treatment.  
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4.2.1 Control sample bacterial growth 
 
Figure 4.1 Biofilm bacteria average growth from control samples 
 
An average biofilm growth pattern was determined from the control group samples. These control 
groups were taken out of the growth tank at the specified dates, as in Figure 4.1, and imaged 
without any exposure to the silver nor copper nanoparticles. 
4.3 Beaker Setup Experiment  
 
4.3.1 Silver (Ag) nanoparticles Treatment 
Samples were exposed to different concentrations of silver nanoparticles for different periods. 
Figure 4.2 shows the reduction in bacterial count on the surfaces of these samples, obtained in 
































Figure 4.2: Beaker set-up Silver nanoparticle treatment results – effects of exposure period 
 
Generally, as expected the higher concentrations of silver nanoparticles had larger reduction in 
biofilm surface bacteria. Similarly, the longer periods yielded higher reduction in the bacterial 
count as well. However, it can be noted from the graph that the ideal exposure time is just over 
12 hours, as there is not much difference between the 12hour and 24hour results. The optimum 
concentration from these set of results can be thought to be around 20mg per25ml as there is no 
significant jump in bacteria reduction between the 20mg and 50mg concentration results. The 
20mg 12hour result is the most optimum in this data set. Figure 4.3 below shows the results set 



































Figure 4.3: Beaker set-up Silver nanoparticle treatment results – effects of concentration  
 
4.3.2 Copper (Cu) nanoparticles Treatment 
Samples were exposed to different concentrations of copper nanoparticles for different periods. 
Figure 4.4 shows the reduction in bacterial count on the surfaces of these samples, obtained in 
comparison with the control samples taken out at the time of testing of each experiment. 
 
Figure 4.4: Beaker set-up Copper nanoparticle treatment results – effects of exposure period 




































































As in the silver nanoparticle beaker experiment, the higher concentrations of silver nanoparticles 
and the longer periods yielded higher reduction in the bacterial count. The difference between the 
3hour and 12hour copper nanoparticle beaker experiment, shows a significant increase of over 
4000per mm2 bacterial count. This indicates copper nanoparticles need more time to react with 
the cell membranes or take longer penetrate the biofilm layer. With this set of results, the 50mg 
24hour experiment would be the optimum solution and exposure time to get the desired reduction. 
Figure 4.5 below shows the results set out to compare the effects of the concentrations.  
 
 
Figure 4.5: Beaker set-up Copper nanoparticle treatment results – effects of concentration 
 
 
4.3.3 Combined Treatment of Silver and Copper (Ag+Cu) 
Samples were exposed to different concentrations of combined silver and copper nanoparticles 
for different periods. Figure 4.6 shows the reduction in bacterial count on the surfaces of these 
samples, obtained in comparison with the control samples taken out at the time of testing of each 
experiment.  







































Figure 4.6: Beaker set-up Silver and Copper nanoparticle mixture treatment results – effects of 
exposure period 
 
In the combined chemical experiment, the overall trend is similar to that of the 2 individual 
experiments. In short, the higher concentrations and longer periods produce higher reduction in 
the surface bacterial count on the samples. However, the 24hour experiment seemed to be less 
effective than the 12hour experiments. The 12hour 50mg experiment having noticeably similar 
reduction than that of the 50mg 24hour experiment going. The results of the combined chemicals 
do not have as big differences between the different exposure periods. The optimum experiment 
of this data set would be the 12hour 50mg concentration of the combined chemicals. The 
synergetic effects of these 2 chemicals are effective within the short time, and thus the results in 
the 24hour experiment is most likely a result of the fact that by the 24th hour most of the bacteria 
have been killed. This trend follows the natural decade logarithm. Figure 4.7 below shows the 

































Figure 4.7: Beaker set-up Silver and Copper nanoparticle mixture treatment results – effects of 
concentration  
 
4.4 Effective Concentration and Effective Exposure Time. 
The beaker setup experiment results are combined below in Figure 4.8. The comparison between 
the silver, copper and combined experimental results can lead to the determination of the effective 
concentration of each and combined chemicals and the most effective exposure time of treatment. 





































Figure 4.8: Beaker set-up summary  
 
The copper nanoparticle treatment yielded the least reduction in all the concentrations and 
exposure periods with only 1 setup giving results above 7000per mm2 bacterial count reduction. 
The silver nanoparticle experiment gave moderate results with 4 setups having reductions above 
7000per mm2 bacterial count. The copper and silver nanoparticle experiment proved synergetic 
effects of the chemicals as it resulted in 6 setups giving a reduction above 7000per mm2 bacterial 
count. The exposure time and concentration needed to reach the 7000per mm2 bacterial count 
for the combined experiment is significantly less. The 12hour 5mg concentration gives a reduction 
above 8000per mm2 bacterial count. 
From the data of the beaker experiment it can be deduced that the optimum concentration and 
exposure time needed to eradicate biofilm bacteria effectively would be a combination of both, 
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4.5 Channel Setup Experiment  
 
4..5.1 Silver (Ag) nanoparticle Treatment  
Samples were exposed to different concentrations of silver nanoparticles and different flow rate 
for 12hours. Figure 4.9 shows the reduction in bacterial count on the surfaces of these samples, 
obtained in comparison with the control samples taken out at the time of testing of each 
experiment. 
 
Figure 4.9: Channel set-up Silver nanoparticle treatment results 
 
The flow rates of F1 (Flow 1) were higher than that of F2 (Flow2) and seen in Table 3.3. The 
effects of flow as expected, aided the reduction in the experiments represented above. All Flow1 
experiments produced higher reductions than that of flow 2. In addition to this trend, the higher 
concentrations also gave larger reduction in the bacterial count on the sample surfaces. In 
comparison to the stationary treatment conditions in the beaker experiment, where the 10mg 
12hour beaker experiment yielded about 6300per mm2 bacterial count, the Flow2 10mg 12hour 
gave a reduction above 8000per mm2 bacterial count.  
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Noted was a large amount of the nanoparticles on the surfaces of the experiment setup as seen 
in Figure A.2 (Appendix A). 
 
4.5.2 Copper (Cu) nanoparticle Treatment 
 
Samples were exposed to different concentrations of Copper nanoparticles and different flow rate 
for 12hours. Figure 4.10 shows the reduction in bacterial count on the surfaces of these samples, 
obtained in comparison with the control samples taken out at the time of testing of each 
experiment. 
 
Figure 4.10: Channel set-up Copper nanoparticle treatment results 
 
The general trend of the copper nanoparticle experiment is similar to that of the silver nanoparticle 
experiment in that the Flow1 experiments have a much greater reduction than that of the Flow2 
experiments. This is because the flow rates of F1 (Flow 1) were higher than that of F2 (Flow2) 
and seen in Table 3.8. Flow can be regarded as a positive factor in the treatment of biofilm 
bacteria. The higher concentrations also yielded larger reductions. In comparison to the stationary 
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experimental results of the copper nanoparticle beaker experiment which had 4800per mm2 
bacterial count reduction, the channel Flow2 10mg 12hour experiment gave about 7600per mm2 
bacterial count reduction. 
Noted was a large amount of the nanoparticles on the surfaces of the experiment setup as seen 
in Figure A.5 (Appendix A). 
 
4.5.3 Combined Treatment of Silver and Copper (Ag+Cu) nanoparticles 
 
Samples were exposed to different concentrations of combined Silver and Copper nanoparticles 
and different flow rate for 12hours. Figure 4.11 shows the reduction in bacterial count on the 
surfaces of these samples, obtained in comparison with the control samples taken out at the time 
of testing of each experiment. 
 
Figure 4.11: Channel set-up Silver and Copper nanoparticle treatment results 
 
The differences Flow1 and Flow2 conditions were not as significant as in the individual chemical 
experiments due to the fact that the flows were not that much different as seen in Table 3.8. the 
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concentration trends remain the same as the higher concentrations have got larger concentration 
reductions. The Flow2 10mg 12hour channel experiment gave a 12000per mm2 bacterial count 
reduction in comparison to the stationary beaker 10mg 12hour experiment which recorded a 
9200per mm2 bacterial count. This again proves that flow has a desired effect in the treatment of 
biofilm bacteria. This can be due to the shear effects that aid the chemicals to infiltrate the biofilm, 
or the chemical circulation helps in making sure that the complete surface area is contacted by 
the chemical. 
 
4.6 Flow effects – Channel Experiment Summary 
 
 
Figure 4.12: Bacterial reduction – effects of flow 
 
Figure 4.12 displays the results at a fixed concentration (10mg per 25ml) and with a exposure 
time of 12H. this then displays the effects of flow of the reduction of bacteria. The results obtained 
show a marked increase in the bacterial reduction given a higher flow. The channel setup 
experiment results are combined below in Figure 4.13. The different flow rate effects can be 
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Figure 4.13: Channel set-up summary  
 
Similar to the beaker experiment, the copper nanoparticle treated samples produced lower 
bacterial count reduction compared to the silver nanoparticle treated samples. The combined 
chemical treatment resulted in greater reductions in bacteria on the surface of the coupon 
samples. This proves the synergetic effects of the copper and silver nanoparticles in eradicating 
biofilm surface bacteria. The silver and copper nanoparticle combined 5mg Flow1 12hour 
experiment has very similar results to the 10mg Flow1 12hour experiment. This finding shows 
that when combined the concentrations needed to treat the bacteria are far less than that needed 

















































Figure 4.14 Results Summary 
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5. Concluding Remarks  
The plausibility of treatment using these chemicals in industry heavily relies on the effective time 
of treatment and cost. Thus, finding the minimum concentration needed to achieve optimum 
reduction of biofilm bacteria in an acceptable time frame. This research aimed to investigate 
antibacterial effects of different copper and silver nanoparticle concentrations, with focus on 
determining the effective treatment time. In addition, the effects of flow and the synergetic effects 
of copper and silver nanoparticles when applied in combination.  
Results displayed in Figure 4.14 summarise the all the experiments conducted. Observed are 2 
general trends, firstly, the higher the concentrations gave higher reductions in biofilm bacteria 
count., secondly, the faster flows give larger reductions in biofilm bacteria count. The results 
support the expected desired synergetic effects of silver and copper nanoparticles. The 
combination of the two chemicals require far less concentration to be effective. Thus, its more 
cost effective and reduces health hazards to end users and limits pipe shut down time to a shorter 
period. The cost of synthesising silver nanoparticles is high; therefore it is an advantage to use 
the silver in combination with the copper because the silver is then required in smaller amounts. 
Use of other heavy metals could be investigated to achieve concentrations that are both harmless 
to the end consumer and that are cost effective to implement. The dislodged or detached dead 
bacteria from the treated biofilm will be present in the water post treatment, thus it is needed to 
investigate to what concentrations and the health impacts that the bacterial residue will have on 
the consumer and the environment.  
The conducted experiment had limitations that include, the biofilm growth time, growth and 
treatment environmental conditions, bacterial count area percentage and chemical adhesion to 
apparatus surfaces. When studying the antibacterial effects of metal ions one should note when 
using 104 cells/mm and using 50ppb metals ions there will be about 2.8x1010 metal ions/ cell 
(Thurman, et al., 1989)The treated bacteria were grown over approximately 150 days. However, 
the biofilm in municipal pipelines have anything up to 10-year growth of biofilm. The difference in 
maturity of the biofilm may change the results obtained herein. Due to the vast number of samples 
the imagery of each sample was taken at less than 25% of the total area. Although random areas 
covering the entire sample were taken to circumvent the error due to this allot more a better 
method of imagery needs to be employed in future research. It was noted during the channel 
experiment and in reviewed literature, the issue of the nanoparticles adhering to the surfaces. 
This decreases the concentration of chemical in circulation. The results given are comparable 
with the literature findings and do show the syngenetic effects of the two chemicals employed.  
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The research gives confidence to warrant future investigations that will bring the technology closer 
to being implemented in industry. The issues of human health impacts need to be more thoroughly 
investigated in collaboration with health experts. In addition, the environmental impacts of having 
these heavy metals in the water would have needs to be assessed. An experiment with a fully 
operational pipeline is necessary in order to determine the cost and application procedure. From 
such an experiment a flushing out system can be obtained and all the environmental 
contingencies taken into consideration. The other future scope stemming from this research could 
be, testing the biofilm bacteria regrowth after chemical treatment, the lag time between application 
and when regrowth commences and thus the interval of treatment needed, the chemical 
concentrations in the actual flow, chemical application in closed channel flow. The above variables 
may affect the effects of the chemicals. One method to increase the interval of treatment is to 
make use of silver nanoparticles being embedded in matrices of the martial used to fabricate the 
pipe lining as done in food processing plants and some medical equipment. A quicker and more 
cost effective application of this research could be making a nanoparticle filter installed at the  
water-meters of each end user , or  treating and flushing out the internal plumbing network of the 
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7. Appendix A 
Herein are tables, equations and figures pertaining to the methodology aspect of the research 
above. 












Table A.2: Flow rates - Copper nanoparticle channel experiment. 
 
T1 T2 T3 AVE Q(l/s)
F1 48.00 47.74 50.16 48.6 0.014393
F2 106.40 140.25 145.78 130.8 0.005351
F1 53.16 49.85 50.90 51.3 0.013644
F2 97.69 97.03 95.09 96.6 0.007246
F1 79.56 80.88 75.90 78.8 0.008886




T1 T2 T3 AVE Q(l/s)
F1 91.43 90.4 91.5 91.1 0.007683
F2 115.5 115.3 116.88 115.9 0.00604
F1 82.19 86.27 73.16 80.5 0.008691
F2 188.17 193.64 192.35 191.4 0.003658
F1 53.42 69.38 51.38 58.1 0.012056


















Figure A.1: Channel setup experiment – Supply tanks (Silver nanoparticles) 
T1 T2 T3 AVE Q(l/s)
F1 33.53 33.07 33.04 33.2 0.021076
F2 162.71 167.26 164.3 164.8 0.004249
F1 49.61 46.94 47.78 48.1 0.01455
F2 67.91 72.08 70.17 70.1 0.009992
F1 32.49 32.12 32.75 32.5 0.021569







Figure A.2: Channel Experiment – Nanoparticle sedimentation in supply tank 
 
 





Figure A.4: Channel Experiment – Coupon layout 
 
 




Figure A.6: Growth Tank 
 
 








Figure A.9: Channel Experiment - Setup design (top view) 
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8. Appendix B 
B.1 Results Tables 
 
Table B.1.1: Results - Silver nanoparticle channel exp. 













11106 12134.49 12699.26 8329.473 11000.87 11648.9 
 
Table B.1.2: Results - Copper nanoparticle channel exp. 













8618.8 9538.258 10068.72 7556.853 8313.096 8862.464 
 
Table B.1.3: Results – Silver and Copper nanoparticle channel exp. 













13486 14092.66 14656.04 12140.39 13220.02 13637.55 
 
Table B.1.4: Results - Channel exp. Summary 
Channel Exp. Summary 
  














CU   8618.836 9538.258 10068.72   7556.853 8313.096 8862.464 
AG   11105.67 12134.49 12699.26   8329.473 11000.87 11648.9 









Table B.1.5: Channel Exp. Results Data 





10 20 50 10 20 50 0 
16949 15920 15355 19725 17054 16406 28055 
Cu 
10 20 50 10 20 50 0 
20288 19368 18838 21350 20593 20044 28906 
AC 
5 10 50 5 10 50 0 
16439 15832 15269 17784 16705 16287 29925 
 
 
Table B.1.6: Beaker Exp. Results Data 
Beaker Exp. Results 
  
3H 12H 24H 
Ag 
10 20 50 10 20 50 10 20 50 
27181 26384 25238 25026 24095 23475 22067 21072 20511 
Cu 
10 20 50 10 20 50 10 20 50 
28402 27665 27107 26391 25323 24889 23065 22649 21788 
AC 
5 10 50 5 10 50 5 10 50 
25023 23857 23021 23023 22002 21366 20647 19805 19218 
CTRL 
0 0 0 




Table B.1.7: Results - Silver nanoparticle beaker exp. 



















1887 2685 3831 6180 7110 7731 7009 8004 8565 
 
Table B.1.8: Results - Copper nanoparticle beaker exp. 



















667 1403 1961 4815 5883 6316 6011 6427 7288 
 
Table B.1.9: Results – Silver and Copper nanoparticle beaker exp. 



















4045 5211 6048 8183 9203 9839 8429 9271 9858 
 
 
B.2 Channel Experiment Data Readings from Images  
For the purpose of the tables below the following are a guidline to the table titles given. 
C  –  Channel experiment 
B - Beaker experiment 
Ag  –  Silver nanoparticles 
Cu  –  Copper nanoparticles 
AC  –  Silver and Copper nanoparticles 
10mg  -  10mg per 25ml concentration 
20mg  –  20mg per 25ml concentration 
50mg - 50mg per 25ml concentration 




Table B.2.1: C-Ag-10mg-12HR-Flow1  Table B.2.2: C-Ag-20mg-12HR-Flow1 
   
 
Table B.2.3: C-Ag-50mg-12HR-Flow1  Table B.2.4: C-Ag-10mg-12HR-Flow2 
    
SAMPLE NUMBER CONC.
C Ag 10 12 F1 01 0.0553 741 13400
C Ag 10 12 F1 02 0.0192 356 18542
C Ag 10 12 F1 03 0.021 365 17381
C Ag 10 12 F1 04 0.0171 332 19415
C Ag 10 12 F1 05 0.0163 298 18282
C Ag 10 12 F1 06 0.0145 303 20897
C Ag 10 12 F1 07 0.0192 365 19010
C Ag 10 12 F1 08 0.0252 207 8214
C Ag 10 12 F1 09 0.0145 275 18966
C Ag 10 12 F1 10 0.0171 341 19942
C Ag 10 12 F1 11 0.0282 481 17057
C Ag 10 12 F1 12 0.0267 385 14419
C Ag 10 12 F1 13 0.0192 369 19219
C Ag 10 12 F1 14 0.0192 244 12708
C Ag 10 12 F1 15 0.0171 287 16784
16949
3401




C Ag 20 12 F1 01 0.0145 227 15655.17
C Ag 20 12 F1 02 0.0171 295 17251.46
C Ag 20 12 F1 03 0.0282 350 12411.35
C Ag 20 12 F1 04 0.0267 314 11760.3
C Ag 20 12 F1 05 0.0192 207 10781.25
C Ag 20 12 F1 06 0.0145 263 18137.93
C Ag 20 12 F1 07 0.0171 336 19649.12
C Ag 20 12 F1 08 0.0253 412 16284.58
C Ag 20 12 F1 09 0.0192 357 18593.75
C Ag 20 12 F1 10 0.0192 325 16927.08
C Ag 20 12 F1 11 0.0192 355 18489.58
C Ag 20 12 F1 12 0.0192 369 19218.75
C Ag 20 12 F1 13 0.0256 337 13164.06
C Ag 20 12 F1 14 0.0252 452 17936.51
C Ag 20 12 F1 15 0.024 301 12541.67
15920.17
2994.569




C Ag 50 12 F1 01 0.0176 258 14659.09
C Ag 50 12 F1 02 0.025 446 17840
C Ag 50 12 F1 03 0.057 688 12070.18
C Ag 50 12 F1 04 0.025 364 14560
C Ag 50 12 F1 05 0.0192 301 15677.08
C Ag 50 12 F1 06 0.04 357 8925
C Ag 50 12 F1 07 0.034 555 16323.53
C Ag 50 12 F1 08 0.0192 273 14218.75
C Ag 50 12 F1 09 0.025 432 17280
C Ag 50 12 F1 10 0.024 417 17375
C Ag 50 12 F1 11 0.022 416 18909.09
C Ag 50 12 F1 12 0.038 546 14368.42
C Ag 50 12 F1 13 0.0192 277 14427.08
C Ag 50 12 F1 14 0.0192 344 17916.67
C Ag 50 12 F1 15 0.0192 303 15781.25
15355.41
2546.077




C Ag 10 12 F2 01 0.0192 199 10364.58
C Ag 10 12 F2 02 0.0192 336 17500
C Ag 10 12 F2 03 0.0384 741 19296.88
C Ag 10 12 F2 04 0.0252 479 19007.94
C Ag 10 12 F2 05 0.014 416 29714.29
C Ag 10 12 F2 06 0.0384 665 17317.71
C Ag 10 12 F2 07 0.0216 410 18981.48
C Ag 10 12 F2 08 0.0256 398 15546.88
C Ag 10 12 F2 09 0.0192 447 23281.25
C Ag 10 12 F2 10 0.0256 446 17421.88
C Ag 10 12 F2 11 0.0256 681 26601.56
C Ag 10 12 F2 12 0.0256 665 25976.56
C Ag 10 12 F2 13 0.0192 337 17552.08
C Ag 10 12 F2 14 0.0192 336 17500
C Ag 10 12 F2 15 0.0216 428 19814.81
19725.19
4861.339





Table B.2.5: C-Ag-20mg-12HR-Flow2  Table B.2.6: C-Ag-50mg-12HR-Flow2 
     
 
 
Table B.2.7: Control – C -Ag    Table B.2.8: C-Cu-10mg-12HR-Flow1 
     
 
SAMPLE NUMBER CONC.
C Ag 20 12 F2 01 0.0192 412 21458.33
C Ag 20 12 F2 02 0.025 312 12480
C Ag 20 12 F2 03 0.0192 478 24895.83
C Ag 20 12 F2 04 0.04 336 8400
C Ag 20 12 F2 05 0.034 412 12117.65
C Ag 20 12 F2 06 0.0192 374 19479.17
C Ag 20 12 F2 07 0.025 341 13640
C Ag 20 12 F2 08 0.024 579 24125
C Ag 20 12 F2 09 0.0192 416 21666.67
C Ag 20 12 F2 10 0.0192 332 17291.67
C Ag 20 12 F2 11 0.0192 417 21718.75
C Ag 20 12 F2 12 0.0256 340 13281.25
C Ag 20 12 F2 13 0.0256 347 13554.69
C Ag 20 12 F2 14 0.0256 468 18281.25
C Ag 20 12 F2 15 0.024 322 13416.67
17053.79
5020.795




C Ag 50 12 F2 01 0.0282 410 14539.01
C Ag 50 12 F2 02 0.0267 477 17865.17
C Ag 50 12 F2 03 0.0258 333 12906.98
C Ag 50 12 F2 04 0.0256 397 15507.81
C Ag 50 12 F2 05 0.0256 478 18671.88
C Ag 50 12 F2 06 0.0256 309 12070.31
C Ag 50 12 F2 07 0.0192 369 19218.75
C Ag 50 12 F2 08 0.04 596 14900
C Ag 50 12 F2 09 0.034 444 13058.82
C Ag 50 12 F2 10 0.0192 417 21718.75
C Ag 50 12 F2 11 0.0267 493 18464.42
C Ag 50 12 F2 12 0.0192 288 15000
C Ag 50 12 F2 13 0.0145 365 25172.41
C Ag 50 12 F2 14 0.0171 302 17660.82
C Ag 50 12 F2 15 0.0658 614 9331.307
16405.76
4025.769




Ctrl  C   Ag   01 0.0282 635 22517.7
Ctrl  C   Ag   02 0.0267 497 18614.2
Ctrl  C   Ag   03 0.0145 854 58896.6
Ctrl  C   Ag   04 0.036 924 25666.7
Ctrl  C   Ag   05 0.0253 665 26284.6
Ctrl  C   Ag   06 0.0192 887 46197.9
Ctrl  C   Ag   07 0.0192 552 28750
Ctrl  C   Ag   08 0.0192 547 28489.6
Ctrl  C   Ag   09 0.0192 608 31666.7
Ctrl  C   Ag   10 0.0192 479 24947.9
Ctrl  C   Ag   11 0.038 588 15473.7
Ctrl  C   Ag   12 0.0192 456 23750
Ctrl  C   Ag   13 0.0192 546 28437.5
Ctrl  C   Ag   14 0.0171 473 27660.8
Ctrl  C   Ag   15 0.0251 338 13466.1
28054.7
11409




C Cu 10 12 F1 01 0.0145 288 19862.07
C Cu 10 12 F1 02 0.0171 352 20584.8
C Cu 10 12 F1 03 0.0282 436 15460.99
C Cu 10 12 F1 04 0.0267 471 17640.45
C Cu 10 12 F1 05 0.0145 367 25310.34
C Cu 10 12 F1 06 0.0171 365 21345.03
C Cu 10 12 F1 07 0.0282 471 16702.13
C Cu 10 12 F1 08 0.0267 488 18277.15
C Cu 10 12 F1 09 0.024 500 20833.33
C Cu 10 12 F1 10 0.022 481 21863.64
C Cu 10 12 F1 11 0.038 960 25263.16
C Cu 10 12 F1 12 0.0192 447 23281.25
C Cu 10 12 F1 13 0.0267 488 18277.15
C Cu 10 12 F1 14 0.0145 316 21793.1
C Cu 10 12 F1 15 0.0055 98 17818.18
20287.52
2960.729





Table B.2.9: C-Cu-20mg-12HR-Flow1  Table B.2.10: C-Cu-50mg-12HR-Flow1 
     
 
 
Table B.2.11: C-Cu-10mg-12HR-Flow2  Table B.2.12: C-Cu-20mg-12HR-Flow1 
     
 
SAMPLE NUMBER CONC.
C Cu 20 12 F1 01 0.0253 325 12845.85
C Cu 20 12 F1 02 0.0192 409 21302.08
C Cu 20 12 F1 03 0.0192 355 18489.58
C Cu 20 12 F1 04 0.0192 389 20260.42
C Cu 20 12 F1 05 0.0192 358 18645.83
C Cu 20 12 F1 06 0.0256 471 18398.44
C Cu 20 12 F1 07 0.0282 367 13014.18
C Cu 20 12 F1 08 0.0267 502 18801.5
C Cu 20 12 F1 09 0.0325 607 18676.92
C Cu 20 12 F1 10 0.0154 359 23311.69
C Cu 20 12 F1 11 0.122 1266 10377.05
C Cu 20 12 F1 12 0.046 879 19108.7
C Cu 20 12 F1 13 0.0365 463 12684.93
C Cu 20 12 F1 14 0.0147 480 32653.06
C Ag 20 12 F1 15 0.0123 393 31951.22
19368.1
6360.756




C Cu 50 12 F1 01 0.0256 471 18398.44
C Cu 50 12 F1 02 0.0282 367 13014.18
C Cu 50 12 F1 03 0.0267 502 18801.5
C Cu 50 12 F1 04 0.0325 607 18676.92
C Cu 50 12 F1 05 0.0154 205 13311.69
C Cu 50 12 F1 06 0.122 364 2983.607
C Cu 50 12 F1 07 0.046 301 6543.478
C Cu 50 12 F1 08 0.0365 357 9780.822
C Cu 50 12 F1 09 0.0147 555 37755.1
C Cu 50 12 F1 10 0.0123 273 22195.12
C Cu 50 12 F1 11 0.021 432 20571.43
C Cu 50 12 F1 12 0.0171 417 24385.96
C Cu 50 12 F1 13 0.0163 416 25521.47
C Cu 50 12 F1 14 0.0145 489 33724.14
C Cu 50 12 F1 15 0.0171 289 16900.58
18837.63
9343.287




C Cu 10 12 F2 01 0.0282 557 19751.77
C Cu 10 12 F2 02 0.0267 781 29250.94
C Cu 10 12 F2 03 0.0325 784 24123.08
C Cu 10 12 F2 04 0.0192 363 18906.25
C Cu 10 12 F2 05 0.122 979 8024.59
C Cu 10 12 F2 06 0.0192 367 19114.58
C Cu 10 12 F2 07 0.0192 512 26666.67
C Cu 10 12 F2 08 0.024 479 19958.33
C Cu 10 12 F2 09 0.0192 241 12552.08
C Cu 10 12 F2 10 0.038 788 20736.84
C Cu 10 12 F2 11 0.0253 447 17667.98
C Cu 10 12 F2 12 0.0192 488 25416.67
C Cu 10 12 F2 13 0.021 611 29095.24
C Cu 10 12 F2 14 0.0171 399 23333.33
C Cu 10 12 F2 15 0.0163 418 25644.17
21349.5
5865.424




C Cu 20 12 F2 01 0.046 705 15326.09
C Cu 20 12 F2 02 0.0365 579 15863.01
C Cu 20 12 F2 03 0.024 416 17333.33
C Cu 20 12 F2 04 0.0192 396 20625
C Cu 20 12 F2 05 0.0192 417 21718.75
C Cu 20 12 F2 06 0.0192 367 19114.58
C Cu 20 12 F2 07 0.0192 347 18072.92
C Cu 20 12 F2 08 0.04 667 16675
C Cu 20 12 F2 09 0.034 592 17411.76
C Cu 20 12 F2 10 0.0192 697 36302.08
C Cu 20 12 F2 11 0.0282 447 15851.06
C Cu 20 12 F2 12 0.0267 488 18277.15
C Cu 20 12 F2 13 0.0256 509 19882.81
C Cu 20 12 F2 14 0.0256 704 27500
C Cu 20 12 F2 15 0.0256 741 28945.31
20593.26
5907.688





Table B.2.13: C-Cu-50mg-12HR-Flow2  Table B.2.14: Control – C - Cu 
     
 
 
Table B.2.15: C-AC-5mg-12HR-Flow1  Table B.2.16: C-AC-10mg-12HR-Flow1 
     
 
SAMPLE NUMBER CONC.
C Cu 50 12 F2 01 0.0282 410 14539.01
C Cu 50 12 F2 02 0.0267 398 14906.37
C Cu 50 12 F2 03 0.046 974 21173.91
C Cu 50 12 F2 04 0.0192 446 23229.17
C Cu 50 12 F2 05 0.04 668 16700
C Cu 50 12 F2 06 0.034 669 19676.47
C Cu 50 12 F2 07 0.0192 389 20260.42
C Cu 50 12 F2 08 0.0267 789 29550.56
C Cu 50 12 F2 09 0.0192 697 36302.08
C Cu 50 12 F2 10 0.0145 278 19172.41
C Cu 50 12 F2 11 0.0171 363 21228.07
C Cu 50 12 F2 12 0.046 979 21282.61
C Cu 50 12 F2 13 0.046 367 7978.261
C Cu 50 12 F2 14 0.0365 639 17506.85
C Cu 50 12 F2 15 0.046 789 17152.17
20043.89
6537.06




Ctrl  C   Cu  01 0.0282 987 35000
Ctrl  C   Cu  02 0.0267 497 18614.2
Ctrl  C   Cu  03 0.0145 854 58896.6
Ctrl  C   Cu  04 0.0267 887 29962.5
Ctrl  C   Cu  05 0.046 512 14456.5
Ctrl  C   Cu  06 0.0192 479 46197.9
Ctrl  C   Cu  07 0.04 588 13875
Ctrl  C   Cu  08 0.034 788 23176.5
Ctrl  C   Cu  09 0.0192 608 31666.7
Ctrl  C   Cu  10 0.0267 800 29962.5
Ctrl  C   Cu  11 0.038 665 17500
Ctrl  C   Cu  12 0.0267 887 33221
Ctrl  C   Cu  13 0.0256 555 21679.7
Ctrl  C   Cu  14 0.0256 840 32812.5
Ctrl  C   Cu  15 0.0251 667 26573.7
28906.4
12072.8




C AC 10 12 F1 01 0.0282 478 16950.35
C AC 10 12 F1 02 0.0267 213 7977.528
C AC 10 12 F1 03 0.0145 266 18344.83
C AC 10 12 F1 04 0.036 715 19861.11
C AC 10 12 F1 05 0.0253 463 18300.4
C AC 10 12 F1 06 0.0192 197 10260.42
C AC 10 12 F1 07 0.0192 308 16041.67
C AC 10 12 F1 08 0.0192 206 10729.17
C AC 10 12 F1 09 0.0192 447 23281.25
C AC 10 12 F1 10 0.0192 207 10781.25
C AC 10 12 F1 11 0.038 547 14394.74
C AC 10 12 F1 12 0.0192 447 23281.25
C AC 10 12 F1 13 0.0192 368 19166.67
C AC 10 12 F1 14 0.0171 336 19649.12
C AC 10 12 F1 15 0.0251 441 17569.72
16439.3
4709.006




C AC 20 12 F1 01 0.102 965 9460.784
C AC 20 12 F1 02 0.0253 447 17667.98
C AC 20 12 F1 03 0.0192 334 17395.83
C AC 20 12 F1 04 0.0192 285 14843.75
C AC 20 12 F1 05 0.0192 302 15729.17
C AC 20 12 F1 06 0.0192 333 17343.75
C AC 20 12 F1 07 0.0282 352 12482.27
C AC 20 12 F1 08 0.0267 452 16928.84
C AC 20 12 F1 09 0.0145 236 16275.86
C AC 20 12 F1 10 0.0192 204 10625
C AC 20 12 F1 11 0.04 285 7125
C AC 20 12 F1 12 0.0192 879 45781.25
C AC 20 12 F1 13 0.038 463 12184.21
C AC 20 12 F1 14 0.0789 480 6083.65
C AC 20 12 F1 15 0.036 632 17555.56
15832.19
9155.372





Table B.2.17: C-AC-50mg-12HR-Flow1  Table B.2.18: C-AC-5mg-12HR-Flow2 
     
 
 
Table B.2.19: C-AC-10mg-12HR-Flow2  Table B.2.20: C-AC-50mg-12HR-Flow2 
     
 
SAMPLE NUMBER CONC.
C AC 50 12 F1 01 0.0192 299 15572.92
C AC 50 12 F1 02 0.0192 358 18645.83
C AC 50 12 F1 03 0.0171 284 16608.19
C AC 50 12 F1 04 0.0556 974 17517.99
C AC 50 12 F1 05 0.0192 274 14270.83
C AC 50 12 F1 06 0.038 607 15973.68
C AC 50 12 F1 07 0.0282 359 12730.5
C AC 50 12 F1 08 0.0267 471 17640.45
C AC 50 12 F1 09 0.0145 203 14000
C AC 50 12 F1 10 0.0253 487 19249.01
C AC 50 12 F1 11 0.0192 314 16354.17
C AC 50 12 F1 12 0.0192 259 13489.58
C AC 50 12 F1 13 0.0192 322 16770.83
C AC 50 12 F1 14 0.0192 217 11302.08
C AC 50 12 F1 15 0.032 285 8906.25
15268.82
2830.683




C AC 10 12 F2 01 0.0192 297 15468.75
C AC 10 12 F2 02 0.038 697 18342.11
C AC 10 12 F2 03 0.0253 365 14426.88
C AC 10 12 F2 04 0.0192 410 21354.17
C AC 10 12 F2 05 0.0192 426 22187.5
C AC 10 12 F2 06 0.0192 370 19270.83
C AC 10 12 F2 07 0.0192 302 15729.17
C AC 10 12 F2 08 0.0192 378 19687.5
C AC 10 12 F2 09 0.0192 352 18333.33
C AC 10 12 F2 10 0.0171 257 15029.24
C AC 10 12 F2 11 0.0282 360 12765.96
C AC 10 12 F2 12 0.0267 412 15430.71
C AC 10 12 F2 13 0.0145 257 17724.14
C AC 10 12 F2 14 0.0192 368 19166.67
C AC 10 12 F2 15 0.04 874 21850
17784.46
2880.876




C AC 20 12 F2 01 0.0364 558 15329.67
C AC 20 12 F2 02 0.0253 363 14347.83
C AC 20 12 F2 03 0.0192 207 10781.25
C AC 20 12 F2 04 0.0192 367 19114.58
C AC 20 12 F2 05 0.0192 333 17343.75
C AC 20 12 F2 06 0.0192 365 19010.42
C AC 20 12 F2 07 0.0192 363 18906.25
C AC 20 12 F2 08 0.038 403 10605.26
C AC 20 12 F2 09 0.0258 697 27015.5
C AC 20 12 F2 10 0.0192 365 19010.42
C AC 20 12 F2 11 0.0192 410 21354.17
C AC 20 12 F2 12 0.0171 308 18011.7
C AC 20 12 F2 13 0.0282 370 13120.57
C AC 20 12 F2 14 0.0267 302 11310.86
C AC 20 12 F2 15 0.0145 222 15310.34
16704.84
4431.652




C AC 50 12 F2 01 0.0192 363 18906.25
C AC 50 12 F2 02 0.0192 403 20989.58
C AC 50 12 F2 03 0.038 697 18342.11
C AC 50 12 F2 04 0.0258 596 23100.78
C AC 50 12 F2 05 0.0192 410 21354.17
C AC 50 12 F2 06 0.04 273 6825
C AC 50 12 F2 07 0.034 432 12705.88
C AC 50 12 F2 08 0.0267 417 15617.98
C AC 50 12 F2 09 0.0192 399 20781.25
C AC 50 12 F2 10 0.0145 258 17793.1
C AC 50 12 F2 11 0.0171 374 21871.35
C AC 50 12 F2 12 0.122 887 7270.492
C AC 50 12 F2 13 0.046 569 12369.57
C AC 50 12 F2 14 0.0365 444 12164.38
C Cu 50 12 F2 15 0.0147 209 14217.69
16287.3
5207.664










B.3 Beaker Experiment Data Readings from Images 
 
C  –  Channel experiment 
B - Beaker experiment 
Ag  –  Silver nanoparticles 
Cu  –  Copper nanoparticles 
AC  –  Silver and Copper nanoparticles 
10mg  -  10mg per 25ml concentration 
20mg  –  20mg per 25ml concentration 
50mg - 50mg per 25ml concentration 
3HR ,12HR, 24HR  -  Exposure period in hours  
SAMPLE NUMBER CONC.
Ctrl  C   AC   01 0.0282 887 31453.9
Ctrl  C   AC   02 0.0267 512 19176
Ctrl  C   AC   03 0.0267 474 17752.8
Ctrl  C   AC   04 0.0192 204 10625
Ctrl  C   AC   05 0.0145 441 30413.8
Ctrl  C   AC   06 0.0171 810 47368.4
Ctrl  C   AC   07 0.122 614 5032.79
Ctrl  C   AC   08 0.0192 666 34687.5
Ctrl  C   AC   09 0.0192 794 41354.2
Ctrl  C   AC   10 0.0171 665 38888.9
Ctrl  C   AC   11 0.0251 887 35338.6
Ctrl  C   AC   12 0.0192 555 28906.3
Ctrl  C   AC   13 0.0253 837 33083
Ctrl  C   AC   14 0.0192 774 40312.5
Ctrl  C   AC   15 0.0192 662 34479.2
29924.9
11848.1








Table B.3.1: B-Ag-10mg-3HR   Table B.3.2: B-Ag-20mg-3HR 
     
Table B.3.3: B-Ag-50mg-3HR   Table B.3.4: B-Cu-10mg-3HR 
     
SAMPLE NUMBER CONC.
B Ag 10 3 01 0.0365 632 17315.07
B Ag 10 3 02 0.024 687 28625
B Ag 10 3 03 0.0192 551 28697.92
B Ag 10 3 04 0.0192 478 24895.83
B Ag 10 3 05 0.0171 456 26666.67
B Ag 10 3 06 0.0251 745 29681.27
B Ag 10 3 07 0.0145 304 20965.52
B Ag 10 3 08 0.036 984 27333.33
B Ag 10 3 09 0.0253 571 22569.17
B Ag 10 3 10 0.0192 698 36354.17
B Ag 10 3 11 0.0192 514 26770.83
B Ag 10 3 12 0.0192 567 29531.25
B Ag 10 3 13 0.0267 668 25018.73
B Ag 10 3 14 0.0192 471 24531.25
B Ag 10 3 15 0.0145 562 38758.62
27180.98
5404.772




B Ag 20 3 01 0.0145 354 24413.79
B Ag 20 3 02 0.036 641 17805.56
B Ag 20 3 03 0.0253 645 25494.07
B Ag 20 3 04 0.0192 639 33281.25
B Ag 20 3 05 0.0192 704 36666.67
B Ag 20 3 06 0.0192 574 29895.83
B Ag 20 3 07 0.0365 984 26958.9
B Ag 20 3 08 0.024 571 23791.67
B Ag 20 3 09 0.0192 603 31406.25
B Ag 20 3 10 0.0192 514 26770.83
B Ag 20 3 11 0.0171 354 20701.75
B Ag 20 3 12 0.0251 478 19043.82
B Ag 20 3 13 0.0267 654 24494.38
B Ag 20 3 14 0.0192 511 26614.58
B Ag 20 3 15 0.0145 412 28413.79
26383.54
5142.505




B Ag 50 3 01 0.054 987 18277.78
B Ag 50 3 02 0.02 574 28700
B Ag 50 3 03 0.0145 984 67862.07
B Ag 50 3 04 0.036 571 15861.11
B Ag 50 3 05 0.0253 603 23833.99
B Ag 50 3 06 0.0192 514 26770.83
B Ag 50 3 07 0.0192 354 18437.5
B Ag 50 3 08 0.0192 478 24895.83
B Ag 50 3 09 0.0192 456 23750
B Ag 50 3 10 0.0192 456 23750
B Ag 50 3 11 0.0171 345 20175.44
B Ag 50 3 12 0.0251 571 22749
B Ag 50 3 13 0.0365 665 18219.18
B Ag 50 3 14 0.024 654 27250
B Ag 50 3 15 0.03 541 18033.33
25237.74
12413.48




B Cu 10 3 01 0.0267 887 33220.97
B Cu 10 3 02 0.0192 687 35781.25
B Cu 10 3 03 0.0145 501 34551.72
B Cu 10 3 04 0.0192 645 33593.75
B Cu 10 3 05 0.0192 364 18958.33
B Cu 10 3 06 0.0171 412 24093.57
B Cu 10 3 07 0.0251 941 37490.04
B Cu 10 3 08 0.0145 689 47517.24
B Cu 10 3 09 0.036 571 15861.11
B Cu 10 3 10 0.0253 365 14426.88
B Cu 10 3 11 0.0192 456 23750
B Cu 10 3 12 0.0192 364 18958.33
B Cu 10 3 13 0.0192 412 21458.33
B Cu 10 3 14 0.0365 941 25780.82




B - Cu- 10mg - 3HR 
68 
 
Table B.3.5: B-Cu-20mg-3HR    Table B.3.6: B-Cu-50mg-3HR 
     
 
 
Table B.3.7: B-AC-5mg-3HR    Table B.3.8: B-AC-10mg-3HR 
    
SAMPLE NUMBER CONC.
B Cu 20 3 01 0.0267 874 32734.08
B Cu 20 3 02 0.0192 412 21458.33
B Cu 20 3 03 0.0145 456 31448.28
B Cu 20 3 04 0.02 689 34450
B Cu 20 3 05 0.0145 571 39379.31
B Cu 20 3 06 0.036 665 18472.22
B Cu 20 3 07 0.0253 369 14584.98
B Cu 20 3 08 0.0192 452 23541.67
B Cu 20 3 09 0.0192 369 19218.75
B Cu 20 3 10 0.0192 412 21458.33
B Cu 20 3 11 0.0192 741 38593.75
B Cu 20 3 12 0.0192 631 32864.58
B Cu 20 3 13 0.0171 369 21578.95
B Cu 20 3 14 0.0251 665 26494.02




B - Cu- 20mg - 3HR 
SAMPLE NUMBER CONC.
B Cu 50 3 01 0.03 637 21233.33
B Cu 50 3 02 0.02 478 23900
B Cu 50 3 03 0.0145 650 44827.59
B Cu 50 3 04 0.036 987 27416.67
B Cu 50 3 05 0.0253 456 18023.72
B Cu 50 3 06 0.0192 456 23750
B Cu 50 3 07 0.0192 689 35885.42
B Cu 50 3 08 0.0192 571 29739.58
B Cu 50 3 09 0.0192 665 34635.42
B Cu 50 3 10 0.0192 369 19218.75
B Cu 50 3 11 0.0171 452 26432.75
B Cu 50 3 12 0.0251 574 22868.53
B Cu 50 3 13 0.0365 698 19123.29
B Cu 50 3 14 0.024 741 30875




B - Cu- 50mg - 3HR 
SAMPLE NUMBER CONC.
B AC 10 3 01 0.0192 553 28802.08
B AC 10 3 02 0.0192 530 27604.17
B AC 10 3 03 0.0171 400 23391.81
B AC 10 3 04 0.0251 698 27808.76
B AC 10 3 05 0.02 469 23450
B AC 10 3 06 0.0145 354 24413.79
B AC 10 3 07 0.036 478 13277.78
B AC 10 3 08 0.0253 672 26561.26
B AC 10 3 09 0.0192 496 25833.33
B AC 10 3 10 0.0192 402 20937.5
B AC 10 3 11 0.0192 411 21406.25
B AC 10 3 12 0.03 852 28400
B AC 10 3 13 0.0267 666 24943.82
B AC 10 3 14 0.0192 578 30104.17




B - AC- 5mg - 3HR 
SAMPLE NUMBER CONC.
B AC 20 3 01 0.0267 599 22434.46
B AC 20 3 02 0.0192 666 34687.5
B AC 20 3 03 0.0145 351 24206.9
B AC 20 3 04 0.0192 540 28125
B AC 20 3 05 0.0192 652 33958.33
B AC 20 3 06 0.0171 369 21578.95
B AC 20 3 07 0.0251 469 18685.26
B AC 20 3 08 0.0235 654 27829.79
B AC 20 3 09 0.0145 478 32965.52
B AC 20 3 10 0.036 672 18666.67
B AC 20 3 11 0.0253 496 19604.74
B AC 20 3 12 0.0192 402 20937.5
B AC 20 3 13 0.0192 651 33906.25
B AC 20 3 14 0.0192 352 18333.33




B - AC- 10mg - 3HR 
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Table B.3.9: B-AC-50mg-3HR    Table B.3.10: Control – B – 3HR 
     
 
 
Table B.3.11: B-Ag-10mg-12HR    Table B.3.12: B-Ag-20mg-12HR 
     
SAMPLE NUMBER CONC.
B AC 50 3 01 0.0267 354 13258.43
B AC 50 3 02 0.0192 541 28177.08
B AC 50 3 03 0.0145 366 25241.38
B AC 50 3 04 0.0192 509 26510.42
B AC 50 3 05 0.0192 412 21458.33
B AC 50 3 06 0.0171 540 31578.95
B AC 50 3 07 0.0251 652 25976.1
B AC 50 3 08 0.014 354 25285.71
B AC 50 3 09 0.0145 366 25241.38
B AC 50 3 10 0.036 654 18166.67
B AC 50 3 11 0.0253 478 18893.28
B AC 50 3 12 0.0192 412 21458.33
B AC 50 3 13 0.0192 496 25833.33
B AC 50 3 14 0.0192 444 23125




B - AC- 50mg - 3HR 
SAMPLE NUMBER CONC.
Ctrl  B  3HR   01 0.0282 874 30992.91
Ctrl  B  3HR   02 0.0267 748 28014.98
Ctrl  B  3HR   03 0.0145 887 61172.41
Ctrl  B  3HR   04 0.036 687 19083.33
Ctrl  B  3HR   05 0.0253 501 19802.37
Ctrl  B  3HR   06 0.0192 645 15468.75
Ctrl  B  3HR   07 0.0192 364 33593.75
Ctrl  B  3HR   08 0.0192 412 23281.25
Ctrl  B  3HR   09 0.0192 941 49010.42
Ctrl  B  3HR   10 0.0192 689 35885.42
Ctrl  B  3HR   11 0.038 571 15026.32
Ctrl  B  3HR   12 0.0192 647 33697.92
Ctrl  B  3HR   13 0.0192 297 15468.75
Ctrl  B  3HR   14 0.0171 645 37719.3
Ctrl  B  3HR   15 0.0251 447 17808.76
29068.44
13387.89




B Ag 10 12 01 0.02 354 17700
B Ag 10 12 02 0.0365 699 19150.68
B Ag 10 12 03 0.024 513 21375
B Ag 10 12 04 0.0192 441 22968.75
B Ag 10 12 05 0.0192 403 20989.58
B Ag 10 12 06 0.0171 704 41169.59
B Ag 10 12 07 0.0251 513 20438.25
B Ag 10 12 08 0.03 784 26133.33
B Ag 10 12 09 0.0145 654 45103.45
B Ag 10 12 10 0.036 405 11250
B Ag 10 12 11 0.0253 669 26442.69
B Ag 10 12 12 0.0192 651 33906.25
B Ag 10 12 13 0.0192 450 23437.5
B Ag 10 12 14 0.0192 441 22968.75
B Ag 10 12 15 0.02 447 22350
25025.59
8834.179




B Ag 20 12 01 0.0267 698 26142.32
B Ag 20 12 02 0.0192 441 22968.75
B Ag 20 12 03 0.0145 403 27793.1
B Ag 20 12 04 0.0365 724 19835.62
B Ag 20 12 05 0.024 596 24833.33
B Ag 20 12 06 0.0145 465 32068.97
B Ag 20 12 07 0.036 684 19000
B Ag 20 12 08 0.0253 456 18023.72
B Ag 20 12 09 0.0192 523 27239.58
B Ag 20 12 10 0.0192 478 24895.83
B Ag 20 12 11 0.0192 669 34843.75
B Ag 20 12 12 0.02 651 32550
B Ag 20 12 13 0.0365 658 18027.4
B Ag 20 12 14 0.024 441 18375
B Ag 20 12 15 0.03 445 14833.33
24095.38
6077.43STD




Table B.3.13: B-Ag-50mg-12HR    Table B.3.14: B-Cu-10mg-12HR 
     
 
 
Table B.3.15: B-Cu-20mg-12HR    Table B.3.16: B-Cu-50mg-12HR 
     
SAMPLE NUMBER CONC.
B Ag 50 12 01 0.0267 465 17415.73
B Ag 50 12 02 0.0192 331 17239.58
B Ag 50 12 03 0.0145 456 31448.28
B Ag 50 12 04 0.0192 523 27239.58
B Ag 50 12 05 0.0192 478 24895.83
B Ag 50 12 06 0.0171 396 23157.89
B Ag 50 12 07 0.0251 651 25936.25
B Ag 50 12 08 0.036 636 17666.67
B Ag 50 12 09 0.0253 789 31185.77
B Ag 50 12 10 0.0192 475 24739.58
B Ag 50 12 11 0.0192 455 23697.92
B Ag 50 12 12 0.0192 444 23125
B Ag 50 12 13 0.0365 697 19095.89
B Ag 50 12 14 0.024 513 21375
B Ag 50 12 15 0.033 789 23909.09
23475.2
4474.185STD
B - Ag- 50mg - 12HR 
AVE
SAMPLE NUMBER CONC.
B Cu 10 12 01 0.036 665 18472.22
B Cu 10 12 02 0.0365 668 18301.37
B Cu 10 12 03 0.024 471 19625
B Cu 10 12 04 0.0145 661 45586.21
B Cu 10 12 05 0.036 674 18722.22
B Cu 10 12 06 0.0253 774 30592.89
B Cu 10 12 07 0.0192 513 26718.75
B Cu 10 12 08 0.0192 715 37239.58
B Cu 10 12 09 0.0192 654 34062.5
B Cu 10 12 10 0.0192 559 29114.58
B Cu 10 12 11 0.0192 452 23541.67
B Cu 10 12 12 0.0171 321 18771.93
B Cu 10 12 13 0.0251 651 25936.25
B Cu 10 12 14 0.0365 668 18301.37




B - Cu- 10mg - 12HR 
SAMPLE NUMBER CONC.
B Cu 20 12 01 0.0267 462 17303.37
B Cu 20 12 02 0.0192 670 34895.83
B Cu 20 12 03 0.0145 354 24413.79
B Cu 20 12 04 0.0145 699 48206.9
B Cu 20 12 05 0.036 513 14250
B Cu 20 12 06 0.0253 715 28260.87
B Cu 20 12 07 0.0192 896 46666.67
B Cu 20 12 08 0.0192 559 29114.58
B Cu 20 12 09 0.0192 690 35937.5
B Cu 20 12 10 0.52 698 1342.308
B Cu 20 12 11 0.0365 654 17917.81
B Cu 20 12 12 0.024 565 23541.67
B Cu 20 12 13 0.0282 887 31453.9
B Cu 20 12 14 0.0267 684 25617.98




B - Cu- 20mg - 12HR 
SAMPLE NUMBER CONC.
B Cu 50 12 01 0.0145 531 36620.69
B Cu 50 12 02 0.036 781 21694.44
B Cu 50 12 03 0.0253 896 35415.02
B Cu 50 12 04 0.0192 559 29114.58
B Cu 50 12 05 0.0192 558 29062.5
B Cu 50 12 06 0.0192 444 23125
B Cu 50 12 07 0.0365 697 19095.89
B Cu 50 12 08 0.024 412 17166.67
B Cu 50 12 09 0.0192 465 24218.75
B Cu 50 12 10 0.0192 405 21093.75
B Cu 50 12 11 0.0171 321 18771.93
B Cu 50 12 12 0.0251 651 25936.25
B Cu 50 12 13 0.0267 678 25393.26
B Cu 50 12 14 0.0192 412 21458.33




B - Cu- 50mg - 12HR 
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Table B.3.17: B-AC-5mg-12HR    Table B.3.18: B-AC-10mg-12HR 
     
 
 
Table B.3.19: B-AC-50mg-12HR   Table B.3.20: Control – B – 12HR  
     
 
SAMPLE NUMBER CONC.
B AC 10 12 01 0.0365 801 21945.21
B AC 10 12 02 0.024 603 25125
B AC 10 12 03 0.0145 336 23172.41
B AC 10 12 04 0.036 788 21888.89
B AC 10 12 05 0.0253 559 22094.86
B AC 10 12 06 0.0192 452 23541.67
B AC 10 12 07 0.0192 465 24218.75
B AC 10 12 08 0.0192 404 21041.67
B AC 10 12 09 0.0192 458 23854.17
B AC 10 12 10 0.0192 465 24218.75
B AC 10 12 11 0.0171 401 23450.29
B AC 10 12 12 0.0251 654 26055.78
B AC 10 12 13 0.0267 565 21161.05
B AC 10 12 14 0.0192 352 18333.33




B - AC- 5mg - 12HR 
SAMPLE NUMBER CONC.
B AC 20 12 01 0.074 1444 19513.51
B AC 20 12 02 0.0267 559 20936.33
B AC 20 12 03 0.0192 558 29062.5
B AC 20 12 04 0.0145 444 30620.69
B AC 20 12 05 0.024 559 23291.67
B AC 20 12 06 0.0365 690 18904.11
B AC 20 12 07 0.024 556 23166.67
B AC 20 12 08 0.362 654 1806.63
B AC 20 12 09 0.0145 412 28413.79
B AC 20 12 10 0.036 655 18194.44
B AC 20 12 11 0.0253 658 26007.91
B AC 20 12 12 0.0192 559 29114.58
B AC 20 12 13 0.0192 399 20781.25
B AC 20 12 14 0.0192 444 23125




B - AC- 10mg - 12HR 
SAMPLE NUMBER CONC.
B AC 50 12 01 0.0365 799 21890.41
B AC 50 12 02 0.0145 345 23793.1
B AC 50 12 03 0.036 558 15500
B AC 50 12 04 0.0253 444 17549.41
B AC 50 12 05 0.0192 559 29114.58
B AC 50 12 06 0.0192 360 18750
B AC 50 12 07 0.0192 369 19218.75
B AC 50 12 08 0.0241 654 27136.93
B AC 50 12 09 0.0192 368 19166.67
B AC 50 12 10 0.0192 401 20885.42
B AC 50 12 11 0.0171 411 24035.09
B AC 50 12 12 0.0251 558 22231.08
B AC 50 12 13 0.0267 444 16629.21
B AC 50 12 14 0.0192 451 23489.58





B - AC- 50mg - 12HR 
SAMPLE NUMBER CONC.
Ctrl  B  12HR   01 0.0282 667 23652.48
Ctrl  B  12HR   02 0.0267 471 17640.45
Ctrl  B  12HR   03 0.0145 661 45586.21
Ctrl  B  12HR   04 0.036 674 18722.22
Ctrl  B  12HR   05 0.0253 774 30592.89
Ctrl  B  12HR   06 0.0192 513 26718.75
Ctrl  B  12HR   07 0.0192 715 37239.58
Ctrl  B  12HR   08 0.0192 654 34062.5
Ctrl  B  12HR   09 0.0192 779 40572.92
Ctrl  B  12HR   10 0.0192 910 47395.83
Ctrl  B  12HR   11 0.038 804 21157.89
Ctrl  B  12HR   12 0.0192 704 36666.67
Ctrl  B  12HR   13 0.0192 654 34062.5
Ctrl  B  12HR   14 0.0171 551 32222.22
Ctrl  B  12HR   15 0.0251 547 21792.83
31205.73
9438.61





Table B.3.21: B-Ag-10mg-24HR    Table B.3.22: B-Ag-20mg-24HR 
     
 
 
Table B.3.23: B-Ag-50mg-24HR    Table B.3.24: B-Cu-10mg-24HR 
     
 
SAMPLE NUMBER CONC.
B Ag 10 24 01 0.0192 361 18802.08
B Ag 10 24 02 0.0192 345 17968.75
B Ag 10 24 03 0.0171 402 23508.77
B Ag 10 24 04 0.0251 478 19043.82
B Ag 10 24 05 0.0145 303 20896.55
B Ag 10 24 06 0.036 651 18083.33
B Ag 10 24 07 0.0253 613 24229.25
B Ag 10 24 08 0.0192 405 21093.75
B Ag 10 24 09 0.0192 475 24739.58
B Ag 10 24 10 0.0192 441 22968.75
B Ag 10 24 11 0.0267 403 15093.63
B Ag 10 24 12 0.0192 724 37708.33
B Ag 10 24 13 0.0145 333 22965.52
B Ag 10 24 14 0.0365 562 15397.26
B Ag 10 24 15 0.024 684 28500
22066.63
5665.982STD
B - Ag- 10mg - 24HR 
AVE
SAMPLE NUMBER CONC.
B Ag 20 24 01 0.0145 332 22896.55
B Ag 20 24 02 0.036 806 22388.89
B Ag 20 24 03 0.0253 455 17984.19
B Ag 20 24 04 0.0192 444 23125
B Ag 20 24 05 0.0192 364 18958.33
B Ag 20 24 06 0.0192 513 26718.75
B Ag 20 24 07 0.014 448 32000
B Ag 20 24 08 0.0365 669 18328.77
B Ag 20 24 09 0.024 406 16916.67
B Ag 20 24 10 0.074 999 13500
B Ag 20 24 11 0.0282 441 15638.3
B Ag 20 24 12 0.0267 654 24494.38
B Ag 20 24 13 0.0267 565 21161.05
B Ag 20 24 14 0.0192 410 21354.17
B Ag 20 24 15 0.0145 299 20620.69
21072.38
4615.529STD
B - Ag- 20mg - 24HR 
AVE
SAMPLE NUMBER CONC.
B Ag 50 24 01 0.0267 566 21198.5
B Ag 50 24 02 0.0192 368 19166.67
B Ag 50 24 03 0.0145 400 27586.21
B Ag 50 24 04 0.0365 658 18027.4
B Ag 50 24 05 0.024 441 18375
B Ag 50 24 06 0.0282 354 12553.19
B Ag 50 24 07 0.0267 422 15805.24
B Ag 50 24 08 0.0282 513 18191.49
B Ag 50 24 09 0.0267 715 26779.03
B Ag 50 24 10 0.0192 401 20885.42
B Ag 50 24 11 0.0192 559 29114.58
B Ag 50 24 12 0.0192 654 34062.5
B Ag 50 24 13 0.0365 565 15479.45
B Ag 50 24 14 0.098 1203 12275.51
B Ag 50 24 15 0.036 654 18166.67
20511.12
6265.831STD
B - Ag- 50mg - 24HR 
AVE
SAMPLE NUMBER CONC.
B Cu 10 24 01 0.0267 661 24756.55
B Cu 10 24 02 0.0192 677 35260.42
B Cu 10 24 03 0.0145 366 25241.38
B Cu 10 24 04 0.0192 513 26718.75
B Cu 10 24 05 0.0192 452 23541.67
B Cu 10 24 06 0.0171 502 29356.73
B Cu 10 24 07 0.0251 559 22270.92
B Cu 10 24 08 0.052 669 12865.38
B Cu 10 24 09 0.0145 364 25103.45
B Cu 10 24 10 0.036 587 16305.56
B Cu 10 24 11 0.0253 406 16047.43
B Cu 10 24 12 0.0192 499 25989.58
B Cu 10 24 13 0.0192 446 23229.17
B Cu 10 24 14 0.0192 441 22968.75





B - Cu- 10mg - 24HR 
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Table B.3.25: B-Cu-20mg-24HR    Table B.3.26: B-AC-5mg-24HR 
    
 
Table B.3.27: B-Cu-50mg-24HR    Table B.3.28: B-AC-10mg-24HR 




B Cu 20 24 01 0.024 599 24958.33
B Cu 20 24 02 0.0267 565 21161.05
B Cu 20 24 03 0.0192 402 20937.5
B Cu 20 24 04 0.0145 330 22758.62
B Cu 20 24 05 0.0282 669 23723.4
B Cu 20 24 06 0.0267 468 17528.09
B Cu 20 24 07 0.0282 658 23333.33
B Cu 20 24 08 0.0267 441 16516.85
B Cu 20 24 09 0.0365 687 18821.92
B Cu 20 24 10 0.024 699 29125
B Cu 20 24 11 0.0192 513 26718.75
B Cu 20 24 12 0.0192 715 37239.58
B Cu 20 24 13 0.0192 587 30572.92
B Cu 20 24 14 0.0365 559 15315.07




B - Cu- 20mg - 24HR 
SAMPLE NUMBER CONC.
B AC 10 24 01 0.0145 444 30620.69
B AC 10 24 02 0.036 659 18305.56
B AC 10 24 03 0.0253 570 22529.64
B AC 10 24 04 0.0192 369 19218.75
B AC 10 24 05 0.0192 503 26197.92
B AC 10 24 06 0.0192 368 19166.67
B AC 10 24 07 0.0365 547 14986.3
B AC 10 24 08 0.024 478 19916.67
B AC 10 24 09 0.0192 320 16666.67
B AC 10 24 10 0.0192 394 20520.83
B AC 10 24 11 0.0171 325 19005.85
B AC 10 24 12 0.0251 536 21354.58
B AC 10 24 13 0.0267 658 24644.19
B AC 10 24 14 0.0192 334 17395.83





B - AC- 5mg - 24HR 
SAMPLE NUMBER CONC.
B Cu 50 24 01 0.0267 574 21498.13
B Cu 50 24 02 0.0192 354 18437.5
B Cu 50 24 03 0.0145 288 19862.07
B Cu 50 24 04 0.036 654 18166.67
B Cu 50 24 05 0.0365 715 19589.04
B Cu 50 24 06 0.024 674 28083.33
B Cu 50 24 07 0.0365 559 15315.07
B Cu 50 24 08 0.024 654 27250
B Cu 50 24 09 0.0282 565 20035.46
B Cu 50 24 10 0.0267 620 23220.97
B Cu 50 24 11 0.0365 478 13095.89
B Cu 50 24 12 0.024 669 27875
B Cu 50 24 13 0.0267 651 24382.02
B Cu 50 24 14 0.0365 764 20931.51




B - Cu- 50mg - 24HR 
SAMPLE NUMBER CONC.
B AC 20 24 01 0.0282 690 24468.09
B AC 20 24 02 0.0267 556 20823.97
B AC 20 24 03 0.0145 321 22137.93
B AC 20 24 04 0.036 697 19361.11
B AC 20 24 05 0.0253 480 18972.33
B AC 20 24 06 0.0192 490 25520.83
B AC 20 24 07 0.0192 415 21614.58
B AC 20 24 08 0.0192 444 23125
B AC 20 24 09 0.0267 559 20936.33
B AC 20 24 10 0.0192 360 18750
B AC 20 24 11 0.0145 229 15793.1
B AC 20 24 12 0.0365 778 21315.07
B AC 20 24 13 0.024 368 15333.33
B AC 20 24 14 0.0587 877 14940.37





B - AC- 10mg - 24HR 
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Table B.3.29: B-AC-50mg-24HR    Table B.3.30: Control – B – 24HR  















B AC 50 24 01 0.0365 558 15287.67
B AC 50 24 02 0.024 447 18625
B AC 50 24 03 0.0282 578 20496.45
B AC 50 24 04 0.0267 556 20823.97
B AC 50 24 05 0.0267 596 22322.1
B AC 50 24 06 0.0192 412 21458.33
B AC 50 24 07 0.0145 284 19586.21
B AC 50 24 08 0.0282 658 23333.33
B AC 50 24 09 0.0267 456 17078.65
B AC 50 24 10 0.0267 499 18689.14
B AC 50 24 11 0.0192 559 29114.58
B AC 50 24 12 0.0145 225 15517.24
B AC 50 24 13 0.0365 698 19123.29
B AC 50 24 14 0.024 335 13958.33





B - AC- 50mg - 24HR 
SAMPLE NUMBER CONC.
Ctrl  B  24HR   01 0.0282 667 23652.48
Ctrl  B  24HR   02 0.0267 848 31760.3
Ctrl  B  24HR   03 0.0145 874 60275.86
Ctrl  B  24HR   04 0.036 748 20777.78
Ctrl  B  24HR   05 0.0253 945 37351.78
Ctrl  B  24HR   06 0.0192 687 35781.25
Ctrl  B  24HR   07 0.0192 501 26093.75
Ctrl  B  24HR   08 0.0192 297 15468.75
Ctrl  B  24HR   09 0.0192 645 33593.75
Ctrl  B  24HR   10 0.0192 447 23281.25
Ctrl  B  24HR   11 0.038 412 10842.11
Ctrl  B  24HR   12 0.0192 941 49010.42
Ctrl  B  24HR   13 0.0192 398 20729.17
Ctrl  B  24HR   14 0.0171 365 21345.03
Ctrl  B  24HR   15 0.0251 657 26175.3
29075.93
12839.97





B.4 Images form SEM 
Below are some images from the SEM before processing are counting.  
 
Figure B.1- SEM image 
 














Figure B.5- SEM image 
 






Figure B.7- SEM image 
 
 





Figure B.9- SEM image 
 





Figure B.11- SEM image 
 




Figure B.13- SEM image 
 





Figure B.15 - SEM image 
 
 
Figure B.16 – SEM image 
